syndrome	score	normalized_score
MYOCLONIC EPILEPSY OF LAFORA	1.5181308	100.0
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	98.80571555494427
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	85.99757016984306
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	1.058092341	69.69704725047407
YOU-HOOVER-FONG SYNDROME; YHFS	1.054750992	69.4769509978982
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.031174782	67.92397479848245
HAMAMY SYNDROME; HMMS	1.03098534	67.91149616357167
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	1.0	65.87047703662951
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	65.87047703662951
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484125999999999	62.47239038955009
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	42.083896855264385
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5526316	36.40210711751583
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.5520593429999999	36.36441227593827
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	35.42329699127374
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.526469393	34.67879006209478
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.521880982	34.37654924068466
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5188679	34.178076091994186
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	33.903923166567736
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.504606952	33.238700644239614
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.504247193	33.21500314729139
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.503013082	33.13371166700524
TRICHOHEPATOENTERIC SYNDROME 1	0.5021692	33.078124757102614
LEBER CONGENITAL AMAUROSIS, TYPE I	0.5	32.935238518314755
COMBINED SAPOSIN DEFICIENCY	0.5	32.935238518314755
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	32.935238518314755
LEBER CONGENITAL AMAUROSIS, TYPE II	0.5	32.935238518314755
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	32.935238518314755
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	32.935238518314755
IMMUNODEFICIENCY 36; IMD36	0.5	32.935238518314755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.49717729199999994	32.74930539581965
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.49238433299999995	32.43359090007264
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.48869108200000005	32.19031469488664
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	30.71994191804817
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.44841259999999994	29.537151871235334
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.44841259999999994	29.537151871235334
CENTRALOPATHIC EPILEPSY	0.44841259999999994	29.537151871235334
AICARDI SYNDROME; AIC	0.43738651	28.810858063086524
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.3934296	25.915395432330335
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	25.19405442534991
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	25.19405442534991
EPILEPSY, JUVENILE ABSENCE	0.3752738	24.7194642253487
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	24.7194642253487
PHELAN-MCDERMID SYNDROME; PHMDS	0.369158703	24.316659868833433
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.362568782	23.882578628929732
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	23.802402269949336
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	23.69023802165136
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.359313711	23.668165549371633
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	23.04161683565079
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	22.925488370303796
RETT SYNDROME, CONGENITAL VARIANT	0.334248751	22.0171246772676
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.33074978200000005	21.786645920101222
TUBEROUS SCLEROSIS	0.32591575100000003	21.468225992121365
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.317208182	20.894654268262
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.266468882	17.552432372757345
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.265549782	17.491890817312974
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	17.43630390741035
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.252191261	16.61195866653914
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.2521692	16.610505497945237
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.2521692	16.610505497945237
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.250843882	16.523206169060007
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	16.467619259157377
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	16.467619259157377
HYPEREKPLEXIA 1; HKPX1	0.25	16.467619259157377
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.22640296199999999	14.913271109445905
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	14.783186007424392
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	14.783186007424392
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	14.783186007424392
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	14.783186007424392
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	14.783186007424392
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.21444808	14.125797329189291
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.20897076100000003	13.765003713777496
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.200843882	13.229682317228528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.200843882	13.229682317228528
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.2	13.174095407325904
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.2	13.174095407325904
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.2	13.174095407325904
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.2	13.174095407325904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.194414082	12.806148323978409
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	11.997871461405039
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	11.942284551502414
CRANIOLENTICULOSUTURAL DYSPLASIA	0.18111508	11.930136718127319
FRONTOOCULAR SYNDROME	0.169998442	11.197878470023795
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM	0.166667	10.978434796263931
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.166667	10.978434796263931
#602089 HEMANGIOMA, CAPILLARY INFANTILE;;HCI;;HEMANGIOMA, HEREDITARY CAPILLARY	0.166667	10.978434796263931
CHROMOSOME 1P36 DELETION SYNDROME	0.164744303	10.851785827677036
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.16348705000000002	10.768969972811302
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.162568782	10.70848322160383
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.150905033	9.940186510938318
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.15063148299999998	9.922167641944949
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.14837970299999997	9.773841819163406
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.14710419299999997	9.689823366998414
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.146374782	9.641776716472652
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.14497639199999998	9.549664100089398
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14370088199999997	9.465645647924406
DYSTONIA 16; DYT16	0.14285699999999998	9.410058738021782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.141590722	9.326648402100794
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	8.854605940410405
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1324787	8.72643516619253
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.127119392	8.373414991646307
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.126130611	8.308283515491551
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	8.294130584795461
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	8.294130584795461
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.125843882	8.289396539481315
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	8.282810677446237
LATHOSTEROLOSIS	0.11330226099999999	7.463273981398704
MICROPHTHALMIA, SYNDROMIC 3	0.11323039199999999	7.4585399360845575
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.11323039199999999	7.4585399360845575
SPONDYLOCOSTAL DYSOSTOSIS 5	0.11111099999999999	7.318934574016941
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.11111099999999999	7.318934574016941
ACRORENAL-MANDIBULAR SYNDROME	0.11111099999999999	7.318934574016941
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.10946271	7.210360925422236
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	7.12117164080987
WHITE-SUTTON SYNDROME; WHSUS	0.104606952	6.890509829587807
MEIER-GORLIN SYNDROME 5; MGORS5	0.10344471000000001	6.813952394615801
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.103013082	6.785520852353434
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.10248756	6.75090446752019
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.1021692	6.729933942450808
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.1021692	6.729933942450808
SECKEL SYNDROME 2; SCKL2	0.10127551	6.671066155827942
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.10127551	6.671066155827942
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	6.647368658879723
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	6.587047703662952
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	6.587047703662952
DYSTONIA, JUVENILE-ONSET	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	6.587047703662952
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	6.587047703662952
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	6.365385775718403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.095522192	6.292092354624517
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.089731551	5.910660069606651
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.08964492200000002	5.904953776051445
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	5.85033911438988
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.088501741	5.829651898242233
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.08302223199999999	5.468714026485728
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.082715282	5.448495083559335
MENTAL RETARDATION, X-LINKED 98; MRX98	0.081404233	5.36213566051094
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.079897192	5.26286615092718
LISSENCEPHALY 2; LIS2	0.079042492	5.206566654203973
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.0788689	5.19513206635423
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.07819861	5.150979744301347
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	5.146131018486681
LISSENCEPHALY, X-LINKED, 2	0.077517491	5.106114110852635
MCLEOD SYNDROME; MCLDS	0.07692310000000001	5.066961292136356
MYOCLONUS AND ATAXIA	0.07692310000000001	5.066961292136356
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.07692310000000001	5.066961292136356
CANAVAN DISEASE	0.07692310000000001	5.066961292136356
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	5.066961292136356
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.076358482	5.029769635132888
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.07593820299999998	5.002085656914409
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0747864	4.92621584385219
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	4.902311447735597
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	4.902311447735597
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.074053661	4.877949976378847
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.07313791	4.817629021162077
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	4.628158522309145
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	4.628158522309145
MICROHYDRANENCEPHALY; MHAC	0.06953211000000001	4.580113255063399
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.06683697	4.4025830975828955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.065425291	4.309595128430304
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	4.22644741810126
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.0632439	4.165905862656894
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.0632439	4.165905862656894
TRANSALDOLASE DEFICIENCY	0.061390799999999995	4.043841281660315
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	3.9449565215329274
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.059806451999999996	3.939479523108285
AL KAISSI SYNDROME; ALKAS	0.059280522999999995	3.904836328990888
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.056992061	3.7540942453706885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.056831110000000004	3.7434923262211663
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	3.7313451515508413
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.056471351	3.7197948292729452
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	3.7150607839588
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.056294422	3.708140431641331
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.055716551	3.6700757932056973
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.055666743	3.6667949164854567
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.055666743	3.6667949164854567
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.055666743	3.6667949164854567
CHROMOSOME 17q12 DELETION SYNDROME	0.055555600000000004	3.659473874056175
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	3.659473874056175
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	3.659473874056175
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	3.659473874056175
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	3.659473874056175
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	3.659473874056175
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	3.659473874056175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.054822861	3.611208006582832
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.054822861	3.611208006582832
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.054822861	3.611208006582832
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.054391233	3.5827764643204656
POTOCKI-LUPSKI SYNDROME	0.054307083	3.5772334636778336
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.053547351	3.527189554417841
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.053419522	3.518769397208725
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.053276632	3.5093571647449613
WIEDEMANN-STEINER SYNDROME; WDSTS	0.05295303299999999	3.488041544246384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.052916872999999996	3.48565966779674
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.052916872999999996	3.48565966779674
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.052470832999999995	3.456278800219322
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.051573143	3.3971475316883106
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.05083721	3.3486712739113127
FONTAINE PROGEROID SYNDROME; FPS	0.050663690000000004	3.3372414287359167
EPILEPSY, PYRIDOXINE-DEPENDENT	0.050042682	3.2963353355323535
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.048978613	3.226244602902464
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	3.1972212144039234
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	3.1972212144039234
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.047841482	3.1513412414793245
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.04732000299999999	3.1169911709847393
#170100 PROLIDASE DEFICIENCY	0.047120482	3.1038486275359145
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.045043051	2.9670072565552323
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.044843342999999994	2.9538523953272007
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.04425893299999999	2.915357029842224
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0440039	2.8985578844721416
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.043988560999999995	2.8975474972248767
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.043979382	2.896942872116157
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.043979382	2.896942872116157
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.042784682000000004	2.8182474132004964
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.042744392000000006	2.815593491680691
CORNELIA DE LANGE SYNDROME 1	0.042189061	2.779013573797462
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.7577058577561298
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	2.7577058577561298
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.04131515	2.721448639339904
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.7021189478535055
YUNIS-VARON SYNDROME	0.04091451	2.6950582914199486
COFFIN-SIRIS SYNDROME 1; CSS1	0.040565043	2.672038733421389
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.04024668299999999	2.651068208352007
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.040210523	2.648686331902363
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.039702932999999996	2.61525113646334
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.039394	2.594901572380983
ADENYLOSUCCINASE DEFICIENCY	0.039201583	2.582226972801026
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.038277082	2.5213296509101846
BOHRING-OPITZ SYNDROME	0.037994903	2.502742385570466
KOOLEN-DE VRIES SYNDROME; KDVS	0.037994903	2.502742385570466
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.037958742999999996	2.500360509120821
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.037862391999999995	2.4940138227878648
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.037507292	2.4706232163921578
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.037449721	2.466830987158682
HYPERPROLINEMIA, TYPE I	0.037294233	2.456588918425211
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	2.4324715630563585
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	2.4324715630563585
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.036813251	2.4249064046391786
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.036615913	2.4119076564417243
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.036378482000000004	2.3962679632084405
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.036105899999999996	2.3783128568368417
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.035435372	2.3341448576104247
Helsmoortel-van der Aa syndrome	0.035361973	2.329310030466413
EVEN-PLUS SYNDROME	0.035065481999999995	2.3097800268593454
Mental retardation, autosomal dominant 21	0.034909951999999994	2.2995351915658384
BARATELA-SCOTT SYNDROME	0.034890292	2.298240177987299
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.03455019299999999	2.2758376946176178
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.03455019299999999	2.2758376946176178
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.034512051	2.273325262882487
BAKER-GORDON SYNDROME; BAGOS	0.034446222	2.2689890752496424
CHROMOSOME 18Q DELETION SYNDROME	0.034418161	2.2671406837935177
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.034417682	2.267109131835017
DUBOWITZ SYNDROME	0.03406607	2.2439482816632133
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.033686651	2.2189557711364527
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	2.211522221932392
FLOATING-HARBOR SYNDROME	0.0334729	2.2048758907993964
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.03331598	2.1945394955428084
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.033279921999999997	2.192164337881821
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.033176601	2.18535853432392
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.0327709	2.158634815919682
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.032767952	2.1584406297533785
LOEYS-DIETZ SYNDROME 5	0.03243604	2.1365774279791965
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.03200061	2.1078954461631367
3MC SYNDROME 1	0.03157851	2.0800915178059753
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.03157851	2.0800915178059753
CHROMOSOME 10Q26 DELETION SYNDROME	0.031538643000000005	2.0774654594979567
BARAITSER-WINTER SYNDROME 1; BRWS1	0.031220283	2.0564949344285752
MECKEL SYNDROME, TYPE 10; MKS10	0.031218750999999996	2.0563940208577547
AU-KLINE SYNDROME; AUKS	0.031146881999999997	2.0516599755436093
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.031146881999999997	2.0516599755436093
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.031146881999999997	2.0516599755436093
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.030583222000000004	2.014531422457143
KLEEFSTRA SYNDROME	0.030352261	1.9993179112102855
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.9979108519503064
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.9979108519503064
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.9979108519503064
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.030302999999999997	1.996073065640984
VAN MALDERGEM SYNDROME 2; VMLDS2	0.030302999999999997	1.996073065640984
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.030302999999999997	1.996073065640984
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.030302999999999997	1.996073065640984
VAN MALDERGEM SYNDROME 1; VMLDS1	0.030302999999999997	1.996073065640984
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.030302999999999997	1.996073065640984
RECOMBINANT CHROMOSOME 8 SYNDROME	0.030263133	1.993447007332965
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.030073080000000002	1.9809281255607225
SMITH-MAGENIS SYNDROME; SMS	0.029920633	1.9708863689479192
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.029647242	1.9528779733603983
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.029273821999999998	1.92828061982538
TIMOTHY SYNDROME; TS	0.029226273	1.9251485445127652
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.029051083000000002	1.9136086956407183
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.028977522999999998	1.9087632633499034
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.02876307	1.8946371419379673
BARDET-BIEDL SYNDROME 1; BBS1	0.028331442000000002	1.866205599675601
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.02823705	1.8599879536071597
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.028207201	1.8580217857380934
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.028061772	1.8484423081331331
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.028035143000000002	1.8466882432001248
NETHERTON SYNDROME; NETH	0.028013082	1.8452350746062198
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.028013082	1.8452350746062198
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.027931643	1.8398706488268337
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.027931643	1.8398706488268337
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.027702012999999998	1.8247448111849123
CORNELIA DE LANGE SYNDROME 3	0.027702012999999998	1.8247448111849123
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.02746664	1.8092406793933697
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.027291450000000002	1.797700830521323
ROIFMAN SYNDROME; RFMN	0.027266931999999997	1.7960858181653383
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.027256220999999997	1.795380279485799
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0271692	1.789648164703595
IMMUNODEFICIENCY 58; IMD58	0.0271692	1.789648164703595
CASPASE 8 DEFICIENCY	0.0271692	1.789648164703595
CYSTIC FIBROSIS	0.0271692	1.789648164703595
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.0271692	1.789648164703595
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027159682	1.78902120950316
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.78902120950316
HAREL-YOON SYNDROME; HAYOS	0.027159682	1.78902120950316
SECKEL SYNDROME 9; SCKL9	0.027119392000000003	1.7863672879833543
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.026759633	1.7626697910351337
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.026725743	1.760437440568362
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.026510792000000002	1.7462785156588616
Diamond-Blackfan anemia 1	0.026340469999999998	1.7350593242690286
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.733434299600535
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.733434299600535
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.733434299600535
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.026078821	1.7178243798228716
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.026058742	1.716501766514453
BRANCHIOOCULOFACIAL SYNDROME	0.025955421	1.7096959629565516
MUCOPOLYSACCHARIDOSIS, TYPE II	0.025915751	1.7070828811325087
COSTELLO SYNDROME; CSTLO	0.025908841999999998	1.7066277820066624
IMMUNODEFICIENCY 23; IMD23	0.025843882000000002	1.7023488358183632
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.025843882000000002	1.7023488358183632
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.025843882000000002	1.7023488358183632
ALSTROM SYNDROME; ALMS	0.025843882000000002	1.7023488358183632
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.025812250999999998	1.7002652867592172
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.025740382	1.6955312414450716
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.025694632	1.6925176671206459
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.02566691	1.6906916057562364
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.025644052	1.6891859383921335
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.025644052	1.6891859383921335
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.025235282	1.6622600634938705
GAUCHER DISEASE, PERINATAL LETHAL	0.025087020999999998	1.6524940406979425
ICHTHYOSIS VULGARIS	0.025	1.646761925915738
ASTHMA, SUSCEPTIBILITY TO	0.025	1.646761925915738
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.025	1.646761925915738
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.025	1.646761925915738
Yao syndrome	0.025	1.646761925915738
DERMATITIS, ATOPIC	0.025	1.646761925915738
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.025	1.646761925915738
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.025	1.646761925915738
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.025	1.646761925915738
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.025	1.646761925915738
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	0.025	1.646761925915738
NEUTROPHIL CHEMOTACTIC RESPONSE	0.025	1.646761925915738
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.025	1.646761925915738
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.025	1.646761925915738
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.025	1.646761925915738
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.025	1.646761925915738
IGE RESPONSIVENESS, ATOPIC	0.025	1.646761925915738
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.025	1.646761925915738
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.02496611	1.6445295754489668
HARDIKAR SYNDROME	0.0248965	1.6399443315424467
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.024846692	1.6366634548222063
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.024803310999999998	1.6338059276578805
NOONAN SYNDROME 7; NS7	0.024679911	1.6256775107915602
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.024655392999999998	1.6240624984355758
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.024486933	1.6129659578739857
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.024486933	1.6129659578739857
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.024435143	1.6095545258682584
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.024341592000000002	1.603392276871005
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.024337032999999998	1.6030919733661946
INFANTILE SIALIC ACID STORAGE DISEASE	0.024337032999999998	1.6030919733661946
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.024337032999999998	1.6030919733661946
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.024337032999999998	1.6030919733661946
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.024337032999999998	1.6030919733661946
KBG SYNDROME	0.024311743	1.6014261090019386
#256520 NEU-LAXOVA SYNDROME; NLS	0.02400281	1.5810765449195814
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.023909621	1.574938141035015
SCARF SYNDROME	0.02376416	1.5653565555747897
ADAMS-OLIVER SYNDROME 5; AOS5	0.023643050999999998	1.5573790479713605
OGDEN SYNDROME; OGDNS	0.023525432000000002	1.5496314283327894
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.023443343	1.5442241867433293
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.023421281999999998	1.5427710181494243
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.023395992	1.541105153785168
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.023159633	1.5255360737032673
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.023159633	1.5255360737032673
FUMARASE DEFICIENCY; FMRD	0.023156492	1.5253291745348951
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.023156492	1.5253291745348951
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.023156492	1.5253291745348951
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.5193738247060136
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.5193738247060136
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.023066082	1.5193738247060136
MENTAL RETARDATION, X-LINKED 91; MRX91	0.023036233	1.517407656836947
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.0227273	1.49705809275459
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.0227273	1.49705809275459
FIBROCHONDROGENESIS 1; FBCG1	0.0227273	1.49705809275459
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.0227273	1.49705809275459
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0227273	1.49705809275459
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0227273	1.49705809275459
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0227273	1.49705809275459
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0227273	1.49705809275459
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0227273	1.49705809275459
#611363 ATRIAL SEPTAL DEFECT 4; ASD4	0.0227273	1.49705809275459
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0227273	1.49705809275459
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.022634111	1.4909196888700234
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.022577399999999997	1.4871841082467991
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.022577399999999997	1.4871841082467991
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.022577399999999997	1.4871841082467991
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.022577399999999997	1.4871841082467991
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.022577399999999997	1.4871841082467991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.022265943	1.4666682870804018
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.022265943	1.4666682870804018
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.022243882	1.4652151184864965
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.4637869148033884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0222222	1.4637869148033884
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.4637869148033884
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.4637869148033884
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.4637869148033884
EPILEPSY, HOT WATER, 1	0.0222222	1.4637869148033884
KAPUR-TORIELLO SYNDROME	0.022192351	1.461820746934322
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.022189403	1.4616265607680181
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.022189403	1.4616265607680181
KAGAMI-OGATA SYNDROME	0.022167832999999998	1.460205734578338
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.022120482	1.4570867016201767
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.022120482	1.4570867016201767
CRANIOFRONTONASAL SYNDROME; CFNS	0.022120482	1.4570867016201767
OCULOSKELETODENTAL SYNDROME; OCSKD	0.022120482	1.4570867016201767
RITSCHER-SCHINZEL SYNDROME 1	0.022120482	1.4570867016201767
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.022118791	1.4569753146435076
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.022118791	1.4569753146435076
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.021903043	1.442763890963809
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.021880982	1.4413107223699038
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.021871043	1.4406560356986369
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.021871043	1.4406560356986369
Xq28 (MECP2) duplication	0.021871043	1.4406560356986369
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.02168371	1.4283163216239336
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.021422061	1.4110813771777766
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.021422061	1.4110813771777766
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.021422061	1.4110813771777766
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.021422061	1.4110813771777766
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.021422061	1.4110813771777766
SECKEL SYNDROME 7; SCKL7	0.021422061	1.4110813771777766
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.021422061	1.4110813771777766
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.021323950999999997	1.4046188246757128
PTERYGIUM COLLI, ISOLATED	0.0212766	1.4014997917175516
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0212766	1.4014997917175516
SPONDYLOOCULAR SYNDROME; SOS	0.0212766	1.4014997917175516
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.0212766	1.4014997917175516
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0212766	1.4014997917175516
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0212766	1.4014997917175516
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0212766	1.4014997917175516
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0212766	1.4014997917175516
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.0212766	1.4014997917175516
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0212766	1.4014997917175516
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.0212766	1.4014997917175516
LEGIUS SYNDROME	0.0212766	1.4014997917175516
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.0212766	1.4014997917175516
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.021273652	1.4013056055512476
TYSHCHENKO SYNDROME	0.021252082	1.3998847793615674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.021208222	1.396995700238741
WAARDENBURG SYNDROME, TYPE 1; WS1	0.02120304	1.396654359426737
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.02120304	1.396654359426737
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.021147703	1.3930092848389612
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.021027161	1.3850691257960117
WEBB-DATTANI SYNDROME; WEDAS	0.020990433	1.3826498349154104
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.020990433	1.3826498349154104
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.020990433	1.3826498349154104
Congenital disorder of glycosylation, type IIh	0.020987292	1.3824429357470385
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.020987292	1.3824429357470385
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.020987292	1.3824429357470385
BETA-UREIDOPROPIONASE DEFICIENCY	0.020987292	1.3824429357470385
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.020987292	1.3824429357470385
RING CHROMOSOME 14 SYNDROME	0.020987292	1.3824429357470385
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.020913893	1.3776081086030267
ALLAN-HERNDON-DUDLEY SYNDROME	0.02050631	1.3507604219610063
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.02050631	1.3507604219610063
DESANTO-SHINAWI SYNDROME	0.020480832999999997	1.349082239817544
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.020480832999999997	1.349082239817544
CRI-DU-CHAT SYNDROME	0.02042977	1.3457186956486227
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	1.3442978694589425
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.3442978694589425
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.3442978694589425
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.020408199999999998	1.3442978694589425
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.3442978694589425
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.020408199999999998	1.3442978694589425
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.020408199999999998	1.3442978694589425
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.3442978694589425
TEMPLE SYNDROME	0.020408199999999998	1.3442978694589425
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.3442978694589425
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	1.3442978694589425
NEMALINE MYOPATHY 10	0.020408199999999998	1.3442978694589425
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	1.3442978694589425
KNIEST-LIKE DYSPLASIA, LETHAL	0.020408199999999998	1.3442978694589425
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.3442978694589425
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	1.3442978694589425
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	1.3442978694589425
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	1.3442978694589425
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.3442978694589425
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.02038035	1.3424633766734724
PELGER-HUET ANOMALY; PHA	0.020206541999999997	1.3310145608006898
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.020146551	1.3270629250127852
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.020146551	1.3270629250127852
LISSENCEPHALY 5; LIS5	0.020146551	1.3270629250127852
GLUTAMINE DEFICIENCY, CONGENITAL	0.020146551	1.3270629250127852
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.020146551	1.3270629250127852
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.020146551	1.3270629250127852
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.020146551	1.3270629250127852
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02014341	1.3268560258444135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.02014341	1.3268560258444135
300270 ADRENOMYODYSTROPHY	0.020074682	1.3223288796986399
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.020074682	1.3223288796986399
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.020074682	1.3223288796986399
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.019998142	1.3172871533862562
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.019970783	1.3154850030050111
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.019948722	1.3140318344111062
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.019913592	1.3117178045528093
LOWE OCULOCEREBRORENAL SYNDROME	0.019751651	1.3010506736310203
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.019711782	1.298424483582047
PEHO-LIKE SYNDROME; PEHOL	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.019711782	1.298424483582047
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.019711782	1.298424483582047
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.019701843	1.29776979691078
N-ACETYLASPARTATE DEFICIENCY; NACED	0.019701843	1.29776979691078
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.0192308	1.266741969796015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0192308	1.266741969796015
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0192308	1.266741969796015
WARBURG MICRO SYNDROME 2; WARBM2	0.0192308	1.266741969796015
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.01915426	1.2617002434836313
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.019126900999999998	1.2598980931023862
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.018994491999999998	1.2511762491084428
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0188679	1.2428375736794222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0188679	1.2428375736794222
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.2428375736794222
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.2428375736794222
ALCOHOL DEPENDENCE	0.0188679	1.2428375736794222
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.2428375736794222
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	1.2428375736794222
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.2428375736794222
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.2428375736794222
RHEUMATOID ARTHRITIS	0.0188679	1.2428375736794222
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.2428375736794222
THUMBS, CONGENITAL CLASPED	0.0188679	1.2428375736794222
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.2428375736794222
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.2428375736794222
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.2428375736794222
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.2428375736794222
PALMOMENTAL REFLEX	0.0188679	1.2428375736794222
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.2428375736794222
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.2428375736794222
DIASTEMATOMYELIA	0.0188679	1.2428375736794222
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.2428375736794222
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.2428375736794222
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.2428375736794222
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.2428375736794222
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.2428375736794222
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.2428375736794222
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.2428375736794222
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.2428375736794222
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	1.2428375736794222
MYOPATHY, CONGENITAL	0.0188679	1.2428375736794222
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.2428375736794222
CARDIAC ARRHYTHMIA	0.0188679	1.2428375736794222
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.2428375736794222
269800 SENILE PLAQUE FORMATION	0.0188679	1.2428375736794222
MOTION SICKNESS	0.0188679	1.2428375736794222
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.2428375736794222
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.2428375736794222
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	1.2428375736794222
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.2428375736794222
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.2428375736794222
CERVICAL RIB	0.0188679	1.2428375736794222
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.2428375736794222
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.2428375736794222
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.2428375736794222
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.2428375736794222
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.2428375736794222
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.2428375736794222
TRANSSEXUALITY	0.0188679	1.2428375736794222
ERYTHERMALGIA, PRIMARY	0.0188679	1.2428375736794222
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.2428375736794222
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.2428375736794222
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0188679	1.2428375736794222
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.2428375736794222
JUMPING FRENCHMAN OF MAINE	0.0188679	1.2428375736794222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0188679	1.2428375736794222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0188679	1.2428375736794222
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.2428375736794222
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.2428375736794222
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.2428375736794222
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.018857961	1.242182887008155
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.018736672	1.2341935227188592
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.018638082	1.2276993523878181
HALLERMANN-STREIFF SYNDROME; HSS	0.018468969999999998	1.2165598642751994
NIEMANN-PICK DISEASE, TYPE C2	0.018426333	1.2137513447457888
SHUKLA-VERNON SYNDROME; SHUVER	0.018426333	1.2137513447457888
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.018426333	1.2137513447457888
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.018426333	1.2137513447457888
MENTAL RETARDATION, X-LINKED 72	0.018426333	1.2137513447457888
ALAZAMI-YUAN SYNDROME	0.018353032	1.2089229729085267
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.01821115	1.1995771378856155
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.01811256	1.1930829675545742
SMITH-KINGSMORE SYNDROME; SKS	0.017851391	1.175879640937395
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.017779522000000002	1.1711455956232495
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.017779522	1.1711455956232493
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.017744392	1.1688315657649526
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.017582451	1.1581644348431637
AUTISM	0.017582451	1.1581644348431637
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.017582451	1.1581644348431637
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.017582451	1.1581644348431637
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.017582451	1.1581644348431637
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.017582451	1.1581644348431637
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.017582451	1.1581644348431637
COFFIN-SIRIS SYNDROME 6; CSS6	0.017510582	1.153430389529018
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.017510582	1.153430389529018
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.017510582	1.153430389529018
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.017483223	1.151628239147773
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.017483223	1.151628239147773
Pierpont syndrome	0.017400643	1.146188655154088
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.017149391	1.1296385660576809
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.017077521999999998	1.1249045207435353
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.017077521999999998	1.1249045207435353
ELSAHY-WATERS SYNDROME; ESWS	0.017077521999999998	1.1249045207435353
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.017017003	1.1209181053437556
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.017017003	1.1209181053437556
PAINE SYNDROME	0.01690051	1.1132446558623275
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01690051	1.1132446558623275
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01690051	1.1132446558623275
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.0166667	1.0978434796263932
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.0166667	1.0978434796263932
#172700 PICK DISEASE OF BRAIN;;LOBAR ATROPHY OF BRAIN;;DEMENTIA WITH LOBAR ATROPHY AND NEURONAL CYTOPLASMIC INCLUSIONS	0.0166667	1.0978434796263932
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.0166667	1.0978434796263932
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.0166667	1.0978434796263932
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.0166667	1.0978434796263932
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.0166667	1.0978434796263932
Smith-Magenis Syndrome	0.0166667	1.0978434796263932
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	1.0895471589141068
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	1.0895471589141068
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.016468882	1.0848131135999612
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.016468882	1.0848131135999612
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.016468882	1.0848131135999612
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016468882	1.0848131135999612
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.016468882	1.0848131135999612
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	1.0848131135999612
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	1.0848131135999612
ROIFMAN-CHITAYAT SYNDROME	0.016468882	1.0848131135999612
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	1.0848131135999612
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	1.0848131135999612
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.01623364	1.0693176108409106
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.016207713	1.0676097869827816
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.015981409999999998	1.0527031004179612
VERVERI-BRADY SYNDROME; VERBRAS	0.01572359	1.0357203740283774
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.015625	1.029226203697336
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	1.029226203697336
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.015625	1.029226203697336
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.015625	1.029226203697336
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	1.029226203697336
CARNOSINEMIA	0.015625	1.029226203697336
HYDROXYLYSINURIA	0.015625	1.029226203697336
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	1.029226203697336
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	1.029226203697336
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	1.029226203697336
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	1.0290056034697406
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	1.0290056034697406
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.015549782	1.024271558155595
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.015549782	1.024271558155595
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	1.024271558155595
AYME-GRIPP SYNDROME; AYGRP	0.015363831	1.0120228770801567
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.015291962000000001	1.0072888317660111
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.015291962000000001	1.0072888317660111
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.015291962	1.0072888317660111
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.015291962	1.0072888317660111
ACROCALLOSAL SYNDROME; ACLS	0.015281251	1.006583293086472
WITTEVEEN-KOLK SYNDROME	0.015231443	1.0033024163662314
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.014913083	0.9823318912968501
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.014897610999999998	0.9813127432761393
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.014825742	0.9765786979619937
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.96868464825297
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.96868464825297
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.0147059	0.96868464825297
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0147059	0.96868464825297
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.96868464825297
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.96868464825297
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.96868464825297
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.96868464825297
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.96868464825297
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.96868464825297
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.96868464825297
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.96868464825297
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0147059	0.96868464825297
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.014529443	0.9570613414865173
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.014529443	0.9570613414865173
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.01444808	0.9517019218633862
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.01444808	0.9517019218633862
227320 FACIOTHORACOGENITAL SYNDROME	0.01444808	0.9517019218633862
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.01444808	0.9517019218633862
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.01444808	0.9517019218633862
MCDONOUGH SYNDROME	0.013981859999999999	0.9209917880593687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.013685560999999999	0.9014744315838924
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.013663499999999999	0.9000212629899874
MARSHALL-SMITH SYNDROME; MRSHSS	0.013663499999999999	0.9000212629899874
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.013637573	0.8983134391318587
GOLDBERG-SHPRINTZEN SYNDROME	0.013613692	0.896740386269747
HOLOPROSENCEPHALY 11	0.013613692	0.896740386269747
HOLOPROSENCEPHALY 5; HPE5	0.013613692	0.896740386269747
DESBUQUOIS DYSPLASIA 2; DBQD2	0.013613692	0.896740386269747
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.013253932999999999	0.8730428893215261
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.013253932999999999	0.8730428893215261
#278250 WRINKLY SKIN SYNDROME; WSS	0.01315345	0.8664240261774545
MEIER-GORLIN SYNDROME 2; MGORS2	0.01315345	0.8664240261774545
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.013112051	0.8636970542986152
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.01276981	0.841153476367122
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.01276981	0.841153476367122
9q subtelomeric deletion syndrome	0.01276981	0.841153476367122
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.01276981	0.841153476367122
GLASS SYNDROME	0.012743883000000001	0.8394456525089933
WIEACKER-WOLFF SYNDROME	0.012743883000000001	0.8394456525089933
ZIMMERMANN-LABAND SYNDROME 1	0.012410050999999998	0.8174559794189011
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.012410050999999998	0.8174559794189011
EPILEPSY-TELANGIECTASIA	0.012410050999999998	0.8174559794189011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.012410050999999998	0.8174559794189011
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.012410050999999998	0.8174559794189011
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.012410050999999998	0.8174559794189011
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.012410050999999998	0.8174559794189011
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.012410050999999998	0.8174559794189011
Temtamy preaxial brachydactyly syndrome	0.012338182	0.8127219341047556
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.012338182	0.8127219341047556
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.012338182	0.8127219341047556
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0121963	0.8033760990818446
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0121963	0.8033760990818446
PSEUDODIASTROPHIC DYSPLASIA	0.01187794	0.7824055740124631
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.011828132000000002	0.7791246972922229
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.011828132000000002	0.7791246972922229
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.011828132000000002	0.7791246972922229
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.011494299999999999	0.7571350242021306
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.011494299999999999	0.7571350242021306
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.011494299999999999	0.7571350242021306
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.011494299999999999	0.7571350242021306
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.011494299999999999	0.7571350242021306
LICHTENSTEIN SYNDROME	0.011494299999999999	0.7571350242021306
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.011494299999999999	0.7571350242021306
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.011494299999999999	0.7571350242021306
PRIMROSE SYNDROME; PRIMS	0.011494299999999999	0.7571350242021306
MENTAL RETARDATION, X-LINKED 73	0.011494299999999999	0.7571350242021306
MENTAL RETARDATION, X-LINKED 97; MRX97	0.011494299999999999	0.7571350242021306
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.011468373	0.755427200344002
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.011468373	0.755427200344002
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.011468373	0.755427200344002
ZTTK SYNDROME; ZTTKS	0.011155733000000001	0.7348334544032702
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.010984250000000001	0.7235377873895978
TEEBI-SHALTOUT SYNDROME; TBSH	0.010984250000000001	0.7235377873895978
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01067161	0.7029440414488659
OHDO SYNDROME	0.010624491	0.699840290441377
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.010624491	0.699840290441377
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.010624491	0.699840290441377
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.010624491	0.699840290441377
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.010624491	0.699840290441377
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.010552622000000001	0.6951062451272315
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.010552622000000001	0.6951062451272315
MENTAL RETARDATION, X-LINKED 107; MRX107	0.010552622000000001	0.6951062451272315
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.010552622000000001	0.6951062451272315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.010262043	0.6759656677804048
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.010262043	0.6759656677804048
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.010262043	0.6759656677804048
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.009943683000000002	0.6549951427110234
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00970874	0.6395193352246065
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00970874	0.6395193352246065
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00970874	0.6395193352246065
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00970874	0.6395193352246065
LATERAL MENINGOCELE SYNDROME	0.00970874	0.6395193352246065
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.00970874	0.6395193352246065
CRANIOECTODERMAL DYSPLASIA 4	0.00970874	0.6395193352246065
RENPENNING SYNDROME 1; RENS1	0.009418161	0.6203787578777797
Myhre syndrome	0.009418161	0.6203787578777797
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.009346292	0.6156447125636342
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.009346292	0.6156447125636342
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.009346291999999999	0.6156447125636342
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009346291999999999	0.6156447125636342
TURNPENNY-FRY SYNDROME; TPFS	0.009027931999999999	0.5946741874942527
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.008986533	0.5919472156154133
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.008986533	0.5919472156154133
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.008986533	0.5919472156154133
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.008668173000000001	0.5709766905460321
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00850241	0.5600578026610092
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00850241	0.5600578026610092
PALLISTER-KILLIAN SYNDROME	0.008142651	0.5363603057127885
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.008070782	0.5316262603986429
COFFIN-SIRIS SYNDROME 7; CSS7	0.008070782	0.5316262603986429
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.008070782	0.5316262603986429
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.008070782	0.5316262603986429
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.008070782	0.5316262603986429
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.008070782	0.5316262603986429
COFFIN-SIRIS SYNDROME 8; CSS8	0.007824290999999999	0.5153897806434069
CHROMOSOME 1p35 DELETION SYNDROME	0.0077744830000000004	0.5121089039231667
COFFIN-SIRIS SYNDROME 5	0.0077744830000000004	0.5121089039231667
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0077744830000000004	0.5121089039231667
PETERS-PLUS SYNDROME; PTRPLS	0.007774483	0.5121089039231665
POPOV-CHANG SYNDROME; POPCHAS	0.007752421999999999	0.5106557353292615
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.007752421999999999	0.5106557353292615
CHROMOSOME 16p13.3 DELETION SYNDROME	0.007691903	0.5066693199294817
#602398 DESMOSTEROLOSIS	0.007691903	0.5066693199294817
C SYNDROME	0.007691903	0.5066693199294817
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.007691903	0.5066693199294817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.007691903	0.5066693199294817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.007691903	0.5066693199294817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.007691903	0.5066693199294817
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.007691902999999999	0.5066693199294816
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.007691902999999999	0.5066693199294816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.007691902999999999	0.5066693199294816
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0072269	0.47603935049601787
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.0072269	0.47603935049601787
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.0072269	0.47603935049601787
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.006930601	0.4565219940205416
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.006930601	0.4565219940205416
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.006930601	0.4565219940205416
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.006930601	0.4565219940205416
AL-RAQAD SYNDROME; ARS	0.006858732	0.4517879487063961
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.006858731999999999	0.451787948706396
%300712 CRANIOFACIOSKELETAL SYNDROME	0.006858731999999999	0.451787948706396
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.006848020999999999	0.4510824100268567
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.006848020999999999	0.4510824100268567
HADZISELIMOVIC SYNDROME	0.006776151999999999	0.4463483647127111
MARINESCO-SJOGREN SYNDROME; MSS	0.006776151999999999	0.4463483647127111
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.006776151999999999	0.4463483647127111
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.006776151999999999	0.4463483647127111
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.006498973	0.42809045175817523
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.006498973	0.42809045175817523
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.006498973	0.42809045175817523
PRADER-WILLI SYNDROME; PWS	0.006498973	0.42809045175817523
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.006498973	0.42809045175817523
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.006498973	0.42809045175817523
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.006498973	0.42809045175817523
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.006416393	0.4226508677644904
LEIGH SYNDROME; LS	0.006416392999999999	0.42265086776449035
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.006416392999999999	0.42265086776449035
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.006416392999999999	0.42265086776449035
Pontine tegmental cap dysplasia	0.006416392999999999	0.42265086776449035
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.006416392999999999	0.42265086776449035
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.006416392999999999	0.42265086776449035
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.006416392999999999	0.42265086776449035
GAUCHER DISEASE, TYPE II	0.006416392999999999	0.42265086776449035
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006416392999999999	0.42265086776449035
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.006416392999999999	0.42265086776449035
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00601485	0.39620103880377106
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00601485	0.39620103880377106
JOHANSON-BLIZZARD SYNDROME; JBS	0.00593227	0.3907614548100862
MEIER-GORLIN SYNDROME 6; MGORS6	0.00593227	0.3907614548100862
JACOBSEN SYNDROME	0.00593227	0.3907614548100862
MEIER-GORLIN SYNDROME 1; MGORS1	0.00593227	0.3907614548100862
BARAITSER-WINTER SYNDROME 2; BRWS2	0.005655091	0.37250354185555024
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.005655091	0.37250354185555024
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005655091	0.37250354185555024
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.005655091	0.37250354185555024
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.005655091	0.37250354185555024
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.005583222	0.3677694965414047
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.005583222	0.3677694965414047
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.005583222	0.3677694965414047
CHROMOSOME 9P DELETION SYNDROME	0.005583222	0.3677694965414047
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.005583222	0.3677694965414047
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.005583222	0.3677694965414047
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.005583222	0.3677694965414047
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.0055725110000000005	0.3670639578618654
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.005572511	0.36706395786186535
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.005522703000000001	0.36378308114162505
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.005522703000000001	0.36378308114162505
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.005522703000000001	0.36378308114162505
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.005522703000000001	0.36378308114162505
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.005522703000000001	0.36378308114162505
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005522703000000001	0.36378308114162505
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.005522703	0.36378308114162494
EMANUEL SYNDROME	0.005522703	0.36378308114162494
MEHMO SYNDROME; MEHMO	0.005522703	0.36378308114162494
KABUKI SYNDROME 1	0.005522703	0.36378308114162494
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.005522703	0.36378308114162494
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.005522703	0.36378308114162494
ADAMS-OLIVER SYNDROME 2; AOS2	0.005522703	0.36378308114162494
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.005522703	0.36378308114162494
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.005522703	0.36378308114162494
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.005522703	0.36378308114162494
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.005522703	0.36378308114162494
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.005522703	0.36378308114162494
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005522703	0.36378308114162494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005522703	0.36378308114162494
#300867 KABUKI SYNDROME 2; KABUK2	0.005522703	0.36378308114162494
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.005522703	0.36378308114162494
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.005522703	0.36378308114162494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005522703	0.36378308114162494
CHROMOSOME 19p13.13 DELETION SYNDROME	0.005522703	0.36378308114162494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.005500642	0.36232991254771985
Aarskog-Scott syndrome	0.005500642	0.36232991254771985
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.005204343	0.3428125560722436
VICI SYNDROME; VICIS	0.005204343	0.3428125560722436
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.005204343	0.3428125560722436
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.005204343	0.3428125560722436
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.005204343	0.3428125560722436
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.005204343	0.3428125560722436
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.005204343	0.3428125560722436
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.005204343	0.3428125560722436
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.005204343	0.3428125560722436
PELIZAEUS-MERZBACHER DISEASE	0.005204343	0.3428125560722436
JABERI-ELAHI SYNDROME; JABELS	0.005204343	0.3428125560722436
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.005204343	0.3428125560722436
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005204343	0.3428125560722436
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.005204343	0.3428125560722436
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.005204342999999999	0.34281255607224353
INFANTILE LIVER FAILURE SYNDROME 1	0.005204342999999999	0.34281255607224353
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.005204342999999999	0.34281255607224353
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005204342999999999	0.34281255607224353
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.005204342999999999	0.34281255607224353
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.005204342999999999	0.34281255607224353
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.005204342999999999	0.34281255607224353
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.005204342999999999	0.34281255607224353
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.005204342999999999	0.34281255607224353
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.005204342999999999	0.34281255607224353
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.005204342999999999	0.34281255607224353
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.00473934	0.31218258663877974
CHROMOSOME 13q14 DELETION SYNDROME	0.00473934	0.31218258663877974
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00473934	0.31218258663877974
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00473934	0.31218258663877974
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00473934	0.31218258663877974
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00473934	0.31218258663877974
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	0.00473934	0.31218258663877974
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00473934	0.31218258663877974
2q37 monosomy	0.00473934	0.31218258663877974
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00473934	0.31218258663877974
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.00473934	0.31218258663877974
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00473934	0.31218258663877974
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00473934	0.31218258663877974
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00473934	0.31218258663877974
HUNTER-MACDONALD SYNDROME	0.00473934	0.31218258663877974
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00473934	0.31218258663877974
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00473934	0.31218258663877974
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00473934	0.31218258663877974
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0046788210000000005	0.308196171239
COCKAYNE SYNDROME A; CSA	0.004678821	0.30819617123899995
SECKEL SYNDROME 1; SCKL1	0.004678821	0.30819617123899995
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.004678821	0.30819617123899995
INCONTINENTIA PIGMENTI; IP	0.004678821	0.30819617123899995
MARDEN-WALKER SYNDROME	0.004678821	0.30819617123899995
CYCLIC VOMITING SYNDROME	0.004678821	0.30819617123899995
MOWAT-WILSON SYNDROME; MOWS	0.004678821	0.30819617123899995
PITT-HOPKINS SYNDROME	0.004678821	0.30819617123899995
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.004678821	0.30819617123899995
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.004656759999999999	0.30674300264509485
ALAGILLE SYNDROME 1; ALGS1	0.004656759999999999	0.30674300264509485
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.004656759999999999	0.30674300264509485
MELNICK-NEEDLES SYNDROME	0.004656759999999999	0.30674300264509485
OROFACIODIGITAL SYNDROME IX; OFD9	0.004606952000000001	0.3034621259248545
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.004606952000000001	0.3034621259248545
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.004606952000000001	0.3034621259248545
CRANIOSYNOSTOSIS 6; CRS6	0.004606952000000001	0.3034621259248545
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.004606952000000001	0.3034621259248545
OPTIC ATROPHY 11; OPA11	0.004606952000000001	0.3034621259248545
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.004606952000000001	0.3034621259248545
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.004606952000000001	0.3034621259248545
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.004606952000000001	0.3034621259248545
MUCOLIPIDOSIS IV; ML4	0.004606952000000001	0.3034621259248545
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.004606952000000001	0.3034621259248545
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.004606952000000001	0.3034621259248545
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.004606952000000001	0.3034621259248545
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.004606952000000001	0.3034621259248545
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.004606952000000001	0.3034621259248545
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.004606952000000001	0.3034621259248545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.0043604609999999995	0.2872256461696186
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.0043604609999999995	0.2872256461696186
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0043604609999999995	0.2872256461696186
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0043604609999999995	0.2872256461696186
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0043604609999999995	0.2872256461696186
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.0043604609999999995	0.2872256461696186
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0043604609999999995	0.2872256461696186
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0043604609999999995	0.2872256461696186
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.0043604609999999995	0.2872256461696186
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0043604609999999995	0.2872256461696186
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0043604609999999995	0.2872256461696186
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0043604609999999995	0.2872256461696186
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0043604609999999995	0.2872256461696186
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0043604609999999995	0.2872256461696186
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.004288591999999999	0.282491600855473
LIG4 SYNDROME	0.004288591999999999	0.282491600855473
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.004288591999999999	0.282491600855473
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.004288591999999999	0.282491600855473
MEVALONIC ACIDURIA; MEVA	0.004288591999999999	0.282491600855473
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.004288591999999999	0.282491600855473
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.004288591999999999	0.282491600855473
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.004288591999999999	0.282491600855473
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.004288591999999999	0.282491600855473
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.004288591999999999	0.282491600855473
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.004288591999999999	0.282491600855473
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.004288591999999999	0.282491600855473
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.004288591999999999	0.282491600855473
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.004288591999999999	0.282491600855473
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004288591999999999	0.282491600855473
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.004288591999999999	0.282491600855473
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004247193000000001	0.2797646289766337
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.004247193000000001	0.2797646289766337
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.004247193000000001	0.2797646289766337
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004247193000000001	0.2797646289766337
SCHINDLER DISEASE, TYPE I	0.004247193000000001	0.2797646289766337
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.004247193000000001	0.2797646289766337
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.004247193000000001	0.2797646289766337
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.004247193000000001	0.2797646289766337
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.004247193000000001	0.2797646289766337
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.004247193000000001	0.2797646289766337
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.004247193000000001	0.2797646289766337
MENTAL RETARDATION, X-LINKED 90	0.004247193000000001	0.2797646289766337
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004247193000000001	0.2797646289766337
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.004247193000000001	0.2797646289766337
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.004247193	0.2797646289766336
CHROMOSOME 16p13.2 DELETION SYNDROME	0.004247193	0.2797646289766336
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.004247193	0.2797646289766336
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.004247193	0.2797646289766336
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.004247193	0.2797646289766336
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.004247193	0.2797646289766336
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.004247193	0.2797646289766336
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.004247193	0.2797646289766336
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004247193	0.2797646289766336
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.004247193	0.2797646289766336
Muenke syndrome	0.004247193	0.2797646289766336
MENTAL RETARDATION, X-LINKED 104; MRX104	0.004247193	0.2797646289766336
OCULOECTODERMAL SYNDROME; OES	0.004247193	0.2797646289766336
RAYNAUD-CLAES SYNDROME; MRXSRC	0.004247193	0.2797646289766336
GLYCEROL KINASE DEFICIENCY; GKD	0.004247193	0.2797646289766336
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.004247193	0.2797646289766336
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004247193	0.2797646289766336
ANGELMAN SYNDROME	0.004247193	0.2797646289766336
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004247193	0.2797646289766336
WEAVER SYNDROME	0.004247193	0.2797646289766336
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004247193	0.2797646289766336
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.004247193	0.2797646289766336
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.004247193	0.2797646289766336
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.003928833	0.2587941039072522
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.003928833	0.2587941039072522
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.003928833	0.2587941039072522
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.003928833	0.2587941039072522
METHYLMALONIC ACIDURIA, CBLA TYPE	0.003928833	0.2587941039072522
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.003928833	0.2587941039072522
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.003928833	0.2587941039072522
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.003928833	0.2587941039072522
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.003928833	0.2587941039072522
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.003928833	0.2587941039072522
PROPIONIC ACIDEMIA	0.003928833	0.2587941039072522
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.003928833	0.2587941039072522
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.003928833	0.2587941039072522
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.003928833	0.2587941039072522
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.003928833	0.2587941039072522
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.003928833	0.2587941039072522
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.003928833	0.2587941039072522
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.003928833	0.2587941039072522
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.003928833	0.2587941039072522
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.003928833	0.2587941039072522
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.003928833	0.2587941039072522
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.003928833	0.2587941039072522
ARGININOSUCCINIC ACIDURIA	0.003928833	0.2587941039072522
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.003928833	0.2587941039072522
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.003928833	0.2587941039072522
CITRULLINEMIA, CLASSIC	0.003928833	0.2587941039072522
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.003928833	0.2587941039072522
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.003928833	0.2587941039072522
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.003928833	0.2587941039072522
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.003928833	0.2587941039072522
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.003928833	0.2587941039072522
FOLATE MALABSORPTION, HEREDITARY	0.003928833	0.2587941039072522
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.003928833	0.2587941039072522
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.003928833	0.2587941039072522
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.003928833	0.2587941039072522
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.003928833	0.2587941039072522
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.003928833	0.2587941039072522
GRACILE BONE DYSPLASIA; GCLEB	0.003928833	0.2587941039072522
MASA SYNDROME	0.0037630700000000003	0.24787521602222945
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.0037630700000000003	0.24787521602222945
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0037630700000000003	0.24787521602222945
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0037630700000000003	0.24787521602222945
LAMBOTTE SYNDROME	0.0037630700000000003	0.24787521602222945
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.0037630700000000003	0.24787521602222945
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0037630700000000003	0.24787521602222945
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0037630700000000003	0.24787521602222945
SECKEL SYNDROME 5; SCKL5	0.0037630700000000003	0.24787521602222945
FANCONI ANEMIA	0.0037630700000000003	0.24787521602222945
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.0037630700000000003	0.24787521602222945
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.0037630700000000003	0.24787521602222945
FOCAL DERMAL HYPOPLASIA; FDH	0.0037630700000000003	0.24787521602222945
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.0037630700000000003	0.24787521602222945
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.0034447099999999997	0.22690469095284804
MEIER-GORLIN SYNDROME 3; MGORS3	0.0034447099999999997	0.22690469095284804
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0034447099999999997	0.22690469095284804
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0034447099999999997	0.22690469095284804
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.0034447099999999997	0.22690469095284804
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0034447099999999997	0.22690469095284804
WARBURG MICRO SYNDROME 1	0.0034447099999999997	0.22690469095284804
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.0034447099999999997	0.22690469095284804
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.0034447099999999997	0.22690469095284804
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0034447099999999997	0.22690469095284804
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.0034447099999999997	0.22690469095284804
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.0034447099999999997	0.22690469095284804
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.003403311	0.22417771907400863
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.003403311	0.22417771907400863
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.003403311	0.22417771907400863
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.003403311	0.22417771907400863
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.003403311	0.22417771907400863
GAUCHER DISEASE, TYPE IIIC	0.003403311	0.22417771907400863
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.003403311	0.22417771907400863
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.003403311	0.22417771907400863
MENTAL RETARDATION, X-LINKED 1	0.003403311	0.22417771907400863
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.003403311	0.22417771907400863
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.003403311	0.22417771907400863
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.003403311	0.22417771907400863
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.003403311	0.22417771907400863
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.003403311	0.22417771907400863
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.003403311	0.22417771907400863
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.003403311	0.22417771907400863
GAPO SYNDROME; GAPOS	0.003403311	0.22417771907400863
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.003403311	0.22417771907400863
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003403311	0.22417771907400863
CROUZON SYNDROME	0.003403311	0.22417771907400863
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0033314420000000004	0.21944367375986315
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0033314420000000004	0.21944367375986315
MEIER-GORLIN SYNDROME 7	0.0033314420000000004	0.21944367375986315
NEPHRONOPHTHISIS 11; NPHP11	0.0033314420000000004	0.21944367375986315
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.0033314420000000004	0.21944367375986315
JOUBERT SYNDROME 21	0.0033314420000000004	0.21944367375986315
RAHMAN SYNDROME	0.0033314420000000004	0.21944367375986315
JOUBERT SYNDROME 14	0.0033314420000000004	0.21944367375986315
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.0033314420000000004	0.21944367375986315
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.0033314420000000004	0.21944367375986315
3MC SYNDROME 2	0.0033314420000000004	0.21944367375986315
RICHARDS-RUNDLE SYNDROME; RRNS	0.0033314420000000004	0.21944367375986315
LAMB-SHAFFER SYNDROME	0.0033314420000000004	0.21944367375986315
HYPERTRYPTOPHANEMIA; HYPTRP	0.0033314420000000004	0.21944367375986315
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.0033314420000000004	0.21944367375986315
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.0033314420000000004	0.21944367375986315
CHAR SYNDROME	0.0033314420000000004	0.21944367375986315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0033314420000000004	0.21944367375986315
SENIOR-LOKEN SYNDROME 9	0.0033314420000000004	0.21944367375986315
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.0033314420000000004	0.21944367375986315
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0033314420000000004	0.21944367375986315
OROFACIODIGITAL SYNDROME VIII; OFD8	0.0033314420000000004	0.21944367375986315
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.0033314420000000004	0.21944367375986315
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0033314420000000004	0.21944367375986315
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0033314420000000004	0.21944367375986315
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0033314420000000004	0.21944367375986315
JOUBERT SYNDROME 31; JBTS31	0.0033314420000000004	0.21944367375986315
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.0033314420000000004	0.21944367375986315
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.0033314420000000004	0.21944367375986315
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.003084951	0.20320719400462725
RETINITIS PIGMENTOSA 59; RP59	0.003084951	0.20320719400462725
KRABBE DISEASE	0.003084951	0.20320719400462725
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.003084951	0.20320719400462725
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.003084951	0.20320719400462725
GLUTARIC ACIDEMIA I; GA1	0.003084951	0.20320719400462725
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.003084951	0.20320719400462725
HYPER-BETA-ALANINEMIA	0.003084951	0.20320719400462725
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.003084951	0.20320719400462725
GITELMAN SYNDROME	0.003084951	0.20320719400462725
COPPER DEFICIENCY, FAMILIAL BENIGN	0.003084951	0.20320719400462725
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.003084951	0.20320719400462725
HYPOPHOSPHATASIA, INFANTILE	0.003084951	0.20320719400462725
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.003084951	0.20320719400462725
HYPERLEUCINE-ISOLEUCINEMIA	0.003084951	0.20320719400462725
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.003084951	0.20320719400462725
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.003084951	0.20320719400462725
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.003084951	0.20320719400462725
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.003084951	0.20320719400462725
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.003084951	0.20320719400462725
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.003084951	0.20320719400462725
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.003084951	0.20320719400462725
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.003084951	0.20320719400462725
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.003084951	0.20320719400462725
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.003084951	0.20320719400462725
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.003084951	0.20320719400462725
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.003084951	0.20320719400462725
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.003084951	0.20320719400462725
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.003084951	0.20320719400462725
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.0030351430000000006	0.19992631728438687
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0030351430000000006	0.19992631728438687
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.0030351430000000006	0.19992631728438687
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.0030351430000000006	0.19992631728438687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0030351430000000006	0.19992631728438687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0030351430000000006	0.19992631728438687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0030351430000000006	0.19992631728438687
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0030351430000000006	0.19992631728438687
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0030351430000000006	0.19992631728438687
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.0030351430000000006	0.19992631728438687
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0030351430000000006	0.19992631728438687
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0030351430000000006	0.19992631728438687
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0030351430000000006	0.19992631728438687
KLEEFSTRA SYNDROME 2; KLEFS2	0.0030351430000000006	0.19992631728438687
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.0030351430000000006	0.19992631728438687
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0030351430000000006	0.19992631728438687
MACDERMOT-WINTER SYNDROME	0.0030351430000000006	0.19992631728438687
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.0030351430000000006	0.19992631728438687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0030351430000000006	0.19992631728438687
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0030351430000000006	0.19992631728438687
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0030351430000000006	0.19992631728438687
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.0030351430000000006	0.19992631728438687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0030351430000000006	0.19992631728438687
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0030351430000000006	0.19992631728438687
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0030351430000000006	0.19992631728438687
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.0030351430000000006	0.19992631728438687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0030351430000000006	0.19992631728438687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0030351430000000006	0.19992631728438687
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0030351430000000006	0.19992631728438687
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.0030351430000000006	0.19992631728438687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0030351430000000006	0.19992631728438687
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0030351430000000006	0.19992631728438687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0030351430000000006	0.19992631728438687
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.0030351430000000006	0.19992631728438687
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0030351430000000006	0.19992631728438687
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0030351430000000006	0.19992631728438687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0030351430000000006	0.19992631728438687
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.0030351430000000006	0.19992631728438687
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0030351430000000006	0.19992631728438687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0030351430000000006	0.19992631728438687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0030351430000000006	0.19992631728438687
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0030351430000000006	0.19992631728438687
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0030351430000000006	0.19992631728438687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0030351430000000006	0.19992631728438687
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.0030351430000000006	0.19992631728438687
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.0030351430000000006	0.19992631728438687
LISSENCEPHALY 8; LIS8	0.0030351430000000006	0.19992631728438687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.0030351430000000006	0.19992631728438687
LISSENCEPHALY 4	0.0030351430000000006	0.19992631728438687
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.0030351430000000006	0.19992631728438687
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0030351430000000006	0.19992631728438687
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.0030351430000000006	0.19992631728438687
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.0030351430000000006	0.19992631728438687
ADAMS-OLIVER SYNDROME 1; AOS1	0.003035143	0.19992631728438684
AICARDI-GOUTIERES SYNDROME 7	0.003035143	0.19992631728438684
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.003035143	0.19992631728438684
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.003035143	0.19992631728438684
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.003035143	0.19992631728438684
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.003035143	0.19992631728438684
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.003035143	0.19992631728438684
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.003035143	0.19992631728438684
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.003035143	0.19992631728438684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.003035143	0.19992631728438684
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.003035143	0.19992631728438684
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.003035143	0.19992631728438684
HEART AND BRAIN MALFORMATION SYNDROME	0.003035143	0.19992631728438684
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.003035143	0.19992631728438684
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.003035143	0.19992631728438684
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.003035143	0.19992631728438684
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.003035143	0.19992631728438684
COFFIN-SIRIS SYNDROME 4; CSS4	0.003035143	0.19992631728438684
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.003035143	0.19992631728438684
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.003035143	0.19992631728438684
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.003035143	0.19992631728438684
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.003035143	0.19992631728438684
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.003035143	0.19992631728438684
COFFIN-SIRIS SYNDROME 3; CSS3	0.003035143	0.19992631728438684
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.003035143	0.19992631728438684
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.003035143	0.19992631728438684
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.003035143	0.19992631728438684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.003035143	0.19992631728438684
HOLOPROSENCEPHALY 1; HPE1	0.003035143	0.19992631728438684
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.003035143	0.19992631728438684
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.003035143	0.19992631728438684
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.003035143	0.19992631728438684
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.003035143	0.19992631728438684
Glycosylphosphatidylinositol biosynthesis defect 18	0.003035143	0.19992631728438684
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.003035143	0.19992631728438684
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.003035143	0.19992631728438684
HOLOPROSENCEPHALY 2; HPE2	0.003035143	0.19992631728438684
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.003035143	0.19992631728438684
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.003035143	0.19992631728438684
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.003035143	0.19992631728438684
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.003035143	0.19992631728438684
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.003035143	0.19992631728438684
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.003035143	0.19992631728438684
TARP SYNDROME; TARPS	0.0030130819999999994	0.1984731486904817
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.0030130819999999994	0.1984731486904817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0030130819999999994	0.1984731486904817
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.0030130819999999994	0.1984731486904817
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0030130819999999994	0.1984731486904817
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.0030130819999999994	0.1984731486904817
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.0030130819999999994	0.1984731486904817
JOUBERT SYNDROME 2	0.0030130819999999994	0.1984731486904817
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.0030130819999999994	0.1984731486904817
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.0030130819999999994	0.1984731486904817
PEROXISOME BIOGENESIS DISORDER 3B	0.0030130819999999994	0.1984731486904817
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.0030130819999999994	0.1984731486904817
OROFACIODIGITAL SYNDROME VI	0.0030130819999999994	0.1984731486904817
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0030130819999999994	0.1984731486904817
NAVAJO NEUROHEPATOPATHY	0.0030130819999999994	0.1984731486904817
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.0030130819999999994	0.1984731486904817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.0030130819999999994	0.1984731486904817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.0030130819999999994	0.1984731486904817
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0030130819999999994	0.1984731486904817
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.0030130819999999994	0.1984731486904817
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0030130819999999994	0.1984731486904817
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.0030130819999999994	0.1984731486904817
Cerebral creatine deficiency syndrome 3	0.0030130819999999994	0.1984731486904817
NIEMANN-PICK DISEASE, TYPE A	0.0030130819999999994	0.1984731486904817
XIA-GIBBS SYNDROME	0.0030130819999999994	0.1984731486904817
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.0030130819999999994	0.1984731486904817
CHROMOSOME 16Q22 DELETION SYNDROME	0.0030130819999999994	0.1984731486904817
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0030130819999999994	0.1984731486904817
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0030130819999999994	0.1984731486904817
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0030130819999999994	0.1984731486904817
GALACTOSE EPIMERASE DEFICIENCY	0.0030130819999999994	0.1984731486904817
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.0030130819999999994	0.1984731486904817
OROTIC ACIDURIA	0.0030130819999999994	0.1984731486904817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0030130819999999994	0.1984731486904817
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0030130819999999994	0.1984731486904817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0030130819999999994	0.1984731486904817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0030130819999999994	0.1984731486904817
HYPOTONIA-CYSTINURIA SYNDROME	0.0030130819999999994	0.1984731486904817
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00248756	0.16385676385723816
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00248756	0.16385676385723816
HEMIFACIAL MICROSOMIA	0.00248756	0.16385676385723816
#608470 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1;;CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB;;REIS-BUCKLERS CORNEAL DYSTROPHY; RBCD;;CORNEAL DYSTROPHY, GEOGRAPHIC;;GRANULAR CORNEAL DYSTROPHY, TYPE III	0.00248756	0.16385676385723816
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00248756	0.16385676385723816
#614199 NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES;NPHS5	0.00248756	0.16385676385723816
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00248756	0.16385676385723816
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00248756	0.16385676385723816
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00248756	0.16385676385723816
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00248756	0.16385676385723816
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.00248756	0.16385676385723816
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00248756	0.16385676385723816
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.00248756	0.16385676385723816
OPTIC ATROPHY 1; OPA1	0.00248756	0.16385676385723816
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00248756	0.16385676385723816
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00248756	0.16385676385723816
PETERS ANOMALY	0.00248756	0.16385676385723816
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00248756	0.16385676385723816
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00248756	0.16385676385723816
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00248756	0.16385676385723816
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00248756	0.16385676385723816
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00248756	0.16385676385723816
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00248756	0.16385676385723816
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00248756	0.16385676385723816
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00248756	0.16385676385723816
VITREORETINOCHOROIDOPATHY; VRCP	0.00248756	0.16385676385723816
NEPHRONOPHTHISIS 18; NPHP18	0.00248756	0.16385676385723816
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00248756	0.16385676385723816
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00248756	0.16385676385723816
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00248756	0.16385676385723816
DUANE-RADIAL RAY SYNDROME; DRRS	0.00248756	0.16385676385723816
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.00248756	0.16385676385723816
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00248756	0.16385676385723816
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00248756	0.16385676385723816
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00248756	0.16385676385723816
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00248756	0.16385676385723816
GLUTATHIONURIA	0.00248756	0.16385676385723816
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00248756	0.16385676385723816
CHANARIN-DORFMAN SYNDROME	0.00248756	0.16385676385723816
ABDUCENS PALSY	0.00248756	0.16385676385723816
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00248756	0.16385676385723816
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.00248756	0.16385676385723816
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00248756	0.16385676385723816
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00248756	0.16385676385723816
#610048 CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD;;CONGENITAL STROMAL CORNEAL DYSTROPHY	0.00248756	0.16385676385723816
IVIC SYNDROME	0.00248756	0.16385676385723816
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00248756	0.16385676385723816
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00248756	0.16385676385723816
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00248756	0.16385676385723816
SENGERS SYNDROME	0.00248756	0.16385676385723816
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00248756	0.16385676385723816
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00248756	0.16385676385723816
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00248756	0.16385676385723816
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00248756	0.16385676385723816
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00248756	0.16385676385723816
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00248756	0.16385676385723816
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00248756	0.16385676385723816
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00248756	0.16385676385723816
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.00248756	0.16385676385723816
WILLIAMS-BEUREN SYNDROME; WBS	0.00248756	0.16385676385723816
RETINAL CONE DYSTROPHY 3B	0.00248756	0.16385676385723816
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00248756	0.16385676385723816
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00248756	0.16385676385723816
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00248756	0.16385676385723816
Rothmund-Thomson syndrome	0.00248756	0.16385676385723816
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00248756	0.16385676385723816
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.00248756	0.16385676385723816
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00248756	0.16385676385723816
ROBINOW-SORAUF SYNDROME	0.00248756	0.16385676385723816
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00248756	0.16385676385723816
BASAL CELL NEVUS SYNDROME	0.00248756	0.16385676385723816
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00248756	0.16385676385723816
#615058 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F	0.00248756	0.16385676385723816
LEBER CONGENITAL AMAUROSIS 16	0.00248756	0.16385676385723816
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00248756	0.16385676385723816
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00248756	0.16385676385723816
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00248756	0.16385676385723816
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00248756	0.16385676385723816
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00248756	0.16385676385723816
15q26 overgrowth syndrome	0.00248756	0.16385676385723816
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00248756	0.16385676385723816
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00248756	0.16385676385723816
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00248756	0.16385676385723816
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00248756	0.16385676385723816
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00248756	0.16385676385723816
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.00248756	0.16385676385723816
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00248756	0.16385676385723816
SOTOS SYNDROME 2	0.00248756	0.16385676385723816
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00248756	0.16385676385723816
SPASTIC PARAPLEGIA 16, X-LINKED	0.00248756	0.16385676385723816
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00248756	0.16385676385723816
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002191261	0.14433940738176182
LISSENCEPHALY 3; LIS3	0.002191261	0.14433940738176182
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.002191261	0.14433940738176182
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002191261	0.14433940738176182
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002191261	0.14433940738176182
SUPRABULBAR PARESIS, CONGENITAL	0.002191261	0.14433940738176182
MENKES DISEASE	0.002191261	0.14433940738176182
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002191261	0.14433940738176182
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002191261	0.14433940738176182
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.002191261	0.14433940738176182
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.002191261	0.14433940738176182
PERRAULT SYNDROME 3	0.002191261	0.14433940738176182
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.002191261	0.14433940738176182
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.002191261	0.14433940738176182
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002191261	0.14433940738176182
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.002191261	0.14433940738176182
OCULODENTODIGITAL DYSPLASIA; ODDD	0.002191261	0.14433940738176182
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002191261	0.14433940738176182
MICROPHTHALMIA, SYNDROMIC 1	0.002191261	0.14433940738176182
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002191261	0.14433940738176182
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.002191261	0.14433940738176182
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002191261	0.14433940738176182
MENTAL RETARDATION, X-LINKED 102	0.002191261	0.14433940738176182
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.002191261	0.14433940738176182
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.002191261	0.14433940738176182
FILIPPI SYNDROME; FLPIS	0.002191261	0.14433940738176182
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.002191261	0.14433940738176182
Wolf-Hirschhorn Syndrome	0.002191261	0.14433940738176182
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.002191261	0.14433940738176182
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.002191261	0.14433940738176182
KEARNS-SAYRE SYNDROME; KSS	0.002191261	0.14433940738176182
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.002191261	0.14433940738176182
COFFIN-LOWRY SYNDROME; CLS	0.002191261	0.14433940738176182
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.002191261	0.14433940738176182
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.002191261	0.14433940738176182
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.002191261	0.14433940738176182
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002191261	0.14433940738176182
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.002191261	0.14433940738176182
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.002191261	0.14433940738176182
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.002191261	0.14433940738176182
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.002191261	0.14433940738176182
ASPARTYLGLUCOSAMINURIA; AGU	0.002191261	0.14433940738176182
OROFACIODIGITAL SYNDROME I; OFD1	0.002191261	0.14433940738176182
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.002191261	0.14433940738176182
COHEN SYNDROME	0.002191261	0.14433940738176182
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002191261	0.14433940738176182
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.002191261	0.14433940738176182
Angelman syndrome (Type 1)	0.002191261	0.14433940738176182
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.002191261	0.14433940738176182
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.002191261	0.14433940738176182
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.002191261	0.14433940738176182
PSEUDO-TORCH SYNDROME 2	0.002191261	0.14433940738176182
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.002191261	0.14433940738176182
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.002191261	0.14433940738176182
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.002191261	0.14433940738176182
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.002191261	0.14433940738176182
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.002191261	0.14433940738176182
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.002191261	0.14433940738176182
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.002191261	0.14433940738176182
PHENYLKETONURIA	0.002191261	0.14433940738176182
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.002191261	0.14433940738176182
Angelman syndrome (Type 2)	0.002191261	0.14433940738176182
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.002191261	0.14433940738176182
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002191261	0.14433940738176182
XYLOSIDASE DEFICIENCY	0.002191261	0.14433940738176182
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.0021691999999999996	0.14288623878785672
HAWKINSINURIA	0.0021691999999999996	0.14288623878785672
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.0021691999999999996	0.14288623878785672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.0021691999999999996	0.14288623878785672
MANNOSE-BINDING LECTIN DEFICIENCY	0.0021691999999999996	0.14288623878785672
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.0021691999999999996	0.14288623878785672
#614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	0.0021691999999999996	0.14288623878785672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.0021691999999999996	0.14288623878785672
Ullrich congenital muscular dystrophy 1	0.0021691999999999996	0.14288623878785672
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0021691999999999996	0.14288623878785672
#615607 IMMUNODEFICIENCY 17; IMD17;;CD3-GAMMA DEFICIENCY;;SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE	0.0021691999999999996	0.14288623878785672
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.0021691999999999996	0.14288623878785672
IMMUNODEFICIENCY 52; IMD52	0.0021691999999999996	0.14288623878785672
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.0021691999999999996	0.14288623878785672
#260370 PANCREATIC AGENESIS, CONGENITAL; PAGEN;;PANCREATIC HYPOPLASIA, CONGENITAL	0.0021691999999999996	0.14288623878785672
IMMUNODEFICIENCY 57; IMD57	0.0021691999999999996	0.14288623878785672
GALACTOSEMIA	0.0021691999999999996	0.14288623878785672
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0021691999999999996	0.14288623878785672
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.0021691999999999996	0.14288623878785672
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.0021691999999999996	0.14288623878785672
Mulchandani-Bhoj-Conlin syndrome	0.0021691999999999996	0.14288623878785672
ADRENAL HYPOPLASIA, CONGENITAL	0.0021691999999999996	0.14288623878785672
#613501 AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79A DEFECT	0.0021691999999999996	0.14288623878785672
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.0021691999999999996	0.14288623878785672
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.14288623878785672
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.0021691999999999996	0.14288623878785672
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0021691999999999996	0.14288623878785672
GLYCOGEN STORAGE DISEASE IV	0.0021691999999999996	0.14288623878785672
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0021691999999999996	0.14288623878785672
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.0021691999999999996	0.14288623878785672
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.0021691999999999996	0.14288623878785672
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.0021691999999999996	0.14288623878785672
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.0021691999999999996	0.14288623878785672
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.0021691999999999996	0.14288623878785672
CHYLOMICRON RETENTION DISEASE	0.0021691999999999996	0.14288623878785672
#601495 AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGHM DEFECT	0.0021691999999999996	0.14288623878785672
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.0021691999999999996	0.14288623878785672
HYPERCALCEMIA, INFANTILE, 1	0.0021691999999999996	0.14288623878785672
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.0021691999999999996	0.14288623878785672
#557000 PEARSON MARROW-PANCREAS SYNDROME;;SIDEROBLASTIC ANEMIA WITH MARROW CELL VACUOLIZATION AND EXOCRINE PANCREATICDYSFUNCTION	0.0021691999999999996	0.14288623878785672
TRICHOHEPATOENTERIC SYNDROME 2	0.0021691999999999996	0.14288623878785672
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.0021691999999999996	0.14288623878785672
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.0021691999999999996	0.14288623878785672
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.0021691999999999996	0.14288623878785672
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.0021691999999999996	0.14288623878785672
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.0021691999999999996	0.14288623878785672
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0021691999999999996	0.14288623878785672
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.0021691999999999996	0.14288623878785672
NOONAN SYNDROME 8; NS8	0.0021691999999999996	0.14288623878785672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.14288623878785672
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.0021691999999999996	0.14288623878785672
IMMUNODEFICIENCY 46; IMD46	0.0021691999999999996	0.14288623878785672
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0021691999999999996	0.14288623878785672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.0021691999999999996	0.14288623878785672
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.0021691999999999996	0.14288623878785672
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0021691999999999996	0.14288623878785672
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.0021691999999999996	0.14288623878785672
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.0021691999999999996	0.14288623878785672
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.0021691999999999996	0.14288623878785672
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.0021691999999999996	0.14288623878785672
601095 HARROD SYNDROME	0.0021691999999999996	0.14288623878785672
#613291 BILE ACID MALABSORPTION, PRIMARY; PBAM	0.0021691999999999996	0.14288623878785672
#610921 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3;;PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 3;;INTERSTITIAL LUNG DISEASE DUE TO ABCA3 DEFICIENCY	0.0021691999999999996	0.14288623878785672
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.0021691999999999996	0.14288623878785672
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.0021691999999999996	0.14288623878785672
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0021691999999999996	0.14288623878785672
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.0021691999999999996	0.14288623878785672
PORPHYRIA, ACUTE HEPATIC	0.0021691999999999996	0.14288623878785672
BARE LYMPHOCYTE SYNDROME, TYPE II	0.0021691999999999996	0.14288623878785672
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.0021691999999999996	0.14288623878785672
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.0021691999999999996	0.14288623878785672
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.14288623878785672
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.0021691999999999996	0.14288623878785672
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0021691999999999996	0.14288623878785672
CAMPOMELIC DYSPLASIA	0.0021691999999999996	0.14288623878785672
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0021691999999999996	0.14288623878785672
#600802 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,B CELL-POSITIVE, NK CELL-NEGATIVE;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	0.0021691999999999996	0.14288623878785672
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.0021691999999999996	0.14288623878785672
614044 TRYPSINOGEN DEFICIENCY	0.0021691999999999996	0.14288623878785672
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.0021691999999999996	0.14288623878785672
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0021691999999999996	0.14288623878785672
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.0021691999999999996	0.14288623878785672
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.0021691999999999996	0.14288623878785672
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0021691999999999996	0.14288623878785672
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.0021691999999999996	0.14288623878785672
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.0021691999999999996	0.14288623878785672
#613205 MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED;;MDCL	0.0021691999999999996	0.14288623878785672
#607748 HYPERCHOLANEMIA, FAMILIAL; FHCA	0.0021691999999999996	0.14288623878785672
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.0021691999999999996	0.14288623878785672
VALINEMIA	0.0021691999999999996	0.14288623878785672
DIARRHEA 9; DIAR9	0.0021691999999999996	0.14288623878785672
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0021691999999999996	0.14288623878785672
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.0021691999999999996	0.14288623878785672
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.0021691999999999996	0.14288623878785672
TYROSINEMIA, TYPE I; TYRSN1	0.0021691999999999996	0.14288623878785672
#615617 IMMUNODEFICIENCY 19; IMD19;;CD3-DELTA DEFICIENCY;;SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B CELL-POSITIVE,NK CELL-POSITIVE;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.0021691999999999996	0.14288623878785672
#613217 DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5;;ENTEROPATHY, CONGENITAL TUFTING; CTE;;INTESTINAL EPITHELIAL CELL DYSPLASIA	0.0021691999999999996	0.14288623878785672
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.0021691999999999996	0.14288623878785672
BARTH SYNDROME; BTHS	0.0021691999999999996	0.14288623878785672
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.0021691999999999996	0.14288623878785672
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0021691999999999996	0.14288623878785672
#615592 IMMUNODEFICIENCY 15; IMD15	0.0021691999999999996	0.14288623878785672
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0021691999999999996	0.14288623878785672
ENTEROKINASE DEFICIENCY	0.0021691999999999996	0.14288623878785672
#615207 IL21R IMMUNODEFICIENCY	0.0021691999999999996	0.14288623878785672
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	0.0021691999999999996	0.14288623878785672
IMMUNODEFICIENCY 9; IMD9	0.0021691999999999996	0.14288623878785672
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.0021691999999999996	0.14288623878785672
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.0021691999999999996	0.14288623878785672
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.0021691999999999996	0.14288623878785672
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0021691999999999996	0.14288623878785672
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.0021691999999999996	0.14288623878785672
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.0021691999999999996	0.14288623878785672
IMMUNODEFICIENCY 53; IMD53	0.0021691999999999996	0.14288623878785672
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0021691999999999996	0.14288623878785672
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.0021691999999999996	0.14288623878785672
#174900 JUVENILE POLYPOSIS SYNDROME; JPS;;POLYPOSIS, JUVENILE INTESTINAL; PJI;;JUVENILE INTESTINAL POLYPOSIS; JIP;;POLYPOSIS, FAMILIAL, OF ENTIRE GASTROINTESTINAL TRACTJUVENILE POLYPOSIS OF STOMACH, INCLUDED;;JUVENILE POLYPOSIS COLI, INCLUDED	0.0021691999999999996	0.14288623878785672
ERYTHRODERMA, LETHAL CONGENITAL	0.0021691999999999996	0.14288623878785672
HYPERLIPOPROTEINEMIA, TYPE ID	0.0021691999999999996	0.14288623878785672
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0021691999999999996	0.14288623878785672
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0021691999999999996	0.14288623878785672
HYPERCALCEMIA, INFANTILE 2	0.0021691999999999996	0.14288623878785672
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.0021691999999999996	0.14288623878785672
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.0021691999999999996	0.14288623878785672
EDINBURGH MALFORMATION SYNDROME	0.0021691999999999996	0.14288623878785672
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.0021691999999999996	0.14288623878785672
IMMUNODEFICIENCY 22; IMD22	0.0021691999999999996	0.14288623878785672
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0021691999999999996	0.14288623878785672
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.0021691999999999996	0.14288623878785672
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.0021691999999999996	0.14288623878785672
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0021691999999999996	0.14288623878785672
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.0021691999999999996	0.14288623878785672
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.0021691999999999996	0.14288623878785672
#610600 CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY;;CMO II DEFICIENCY;;ALDOSTERONE DEFICIENCY II;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1B;;ALDOSTERONE DEFICIENCY DUE TO DEFICIENCY OF STEROID 18-OXIDASE;;STEROID 18-OXIDASE DEFICIENCY;;18-@OXIDASE DEFICIENCY	0.0021691999999999996	0.14288623878785672
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.0021691999999999996	0.14288623878785672
#610913 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2;;INTERSTITIAL LUNG DISEASE DUE TO SURFACTANT PROTEIN C DEFICIENCY;;DESQUAMATIVE INTERSTITIAL PNEUMONITIS DUE TO SURFACTANT PROTEIN CDEFICIENCY;;PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 2	0.0021691999999999996	0.14288623878785672
CONGENITAL SHORT BOWEL SYNDROME	0.0021691999999999996	0.14288623878785672
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.0021691999999999996	0.14288623878785672
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0021691999999999996	0.14288623878785672
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0021691999999999996	0.14288623878785672
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0021691999999999996	0.14288623878785672
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.0021691999999999996	0.14288623878785672
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	0.0021691999999999996	0.14288623878785672
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.0021691999999999996	0.14288623878785672
#269840 SELECTIVE T-CELL DEFECT; STCD	0.0021691999999999996	0.14288623878785672
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0021193920000000003	0.1396053620676163
HOLOPROSENCEPHALY 3; HPE3	0.0021193920000000003	0.1396053620676163
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0021193920000000003	0.1396053620676163
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.0021193920000000003	0.1396053620676163
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.0021193920000000003	0.1396053620676163
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0021193920000000003	0.1396053620676163
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.0021193920000000003	0.1396053620676163
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0021193920000000003	0.1396053620676163
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0021193920000000003	0.1396053620676163
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0021193920000000003	0.1396053620676163
HARTSFIELD SYNDROME; HRTFDS	0.0021193920000000003	0.1396053620676163
WARSAW BREAKAGE SYNDROME; WABS	0.0021193920000000003	0.1396053620676163
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021193920000000003	0.1396053620676163
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.0021193920000000003	0.1396053620676163
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0021193920000000003	0.1396053620676163
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.0021193920000000003	0.1396053620676163
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0021193920000000003	0.1396053620676163
GENITOPATELLAR SYNDROME; GTPTS	0.0021193920000000003	0.1396053620676163
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0021193920000000003	0.1396053620676163
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0021193920000000003	0.1396053620676163
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.0021193920000000003	0.1396053620676163
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0021193920000000003	0.1396053620676163
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0021193920000000003	0.1396053620676163
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0021193920000000003	0.1396053620676163
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0021193920000000003	0.1396053620676163
SECKEL SYNDROME 8; SCKL8	0.0021193920000000003	0.1396053620676163
#614728 SECKEL SYNDROME 6; SCKL6	0.0021193920000000003	0.1396053620676163
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.0021193920000000003	0.1396053620676163
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0021193920000000003	0.1396053620676163
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.0021193920000000003	0.1396053620676163
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.0021193920000000003	0.1396053620676163
FORSYTHE-WAKELING SYNDROME; FWS	0.0021193920000000003	0.1396053620676163
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0021193920000000003	0.1396053620676163
CEREBELLOFACIODENTAL SYNDROME	0.0021193920000000003	0.1396053620676163
LOWRY-MACLEAN SYNDROME	0.0021193920000000003	0.1396053620676163
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.0021193920000000003	0.1396053620676163
ADAMS-OLIVER SYNDROME 3; AOS3	0.0021193920000000003	0.1396053620676163
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0021193920000000003	0.1396053620676163
AICARDI-GOUTIERES SYNDROME 6	0.0021193920000000003	0.1396053620676163
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0021193920000000003	0.1396053620676163
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0021193920000000003	0.1396053620676163
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021193920000000003	0.1396053620676163
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0021193920000000003	0.1396053620676163
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0021193920000000003	0.1396053620676163
TOWNES-BROCKS SYNDROME 1; TBS1	0.0021193920000000003	0.1396053620676163
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0021193920000000003	0.1396053620676163
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.0021193920000000003	0.1396053620676163
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0021193920000000003	0.1396053620676163
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.0021193920000000003	0.1396053620676163
RAINE SYNDROME	0.0021193920000000003	0.1396053620676163
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.0021193920000000003	0.1396053620676163
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0021193920000000003	0.1396053620676163
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021193920000000003	0.1396053620676163
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0021193920000000003	0.1396053620676163
ALAZAMI SYNDROME; ALAZS	0.0021193920000000003	0.1396053620676163
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0021193920000000003	0.1396053620676163
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.0021193920000000003	0.1396053620676163
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021193920000000003	0.1396053620676163
DYSTONIA 28, CHILDHOOD-ONSET	0.0021193920000000003	0.1396053620676163
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.0021193920000000003	0.1396053620676163
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.0021193920000000003	0.1396053620676163
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0021193920000000003	0.1396053620676163
AICARDI-GOUTIERES SYNDROME 5	0.0021193920000000003	0.1396053620676163
Leukotriene C4 synthase deficiency	0.0021193920000000003	0.1396053620676163
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0021193920000000003	0.1396053620676163
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0021193920000000003	0.1396053620676163
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0021193920000000003	0.1396053620676163
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.0021193920000000003	0.1396053620676163
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0021193920000000003	0.1396053620676163
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0021193920000000003	0.1396053620676163
OROFACIODIGITAL SYNDROME XIV; OFD14	0.0021193920000000003	0.1396053620676163
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.0021193920000000003	0.1396053620676163
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0021193920000000003	0.1396053620676163
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.0021193920000000003	0.1396053620676163
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0021193920000000003	0.1396053620676163
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001759633	0.1159078651193955
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.001759633	0.1159078651193955
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.1159078651193955
HOLOPROSENCEPHALY 7	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001759633	0.1159078651193955
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.1159078651193955
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001759633	0.1159078651193955
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001759633	0.1159078651193955
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001759633	0.1159078651193955
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001759633	0.1159078651193955
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001759633	0.1159078651193955
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.001759633	0.1159078651193955
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.001759633	0.1159078651193955
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.1159078651193955
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.1159078651193955
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001759633	0.1159078651193955
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001759633	0.1159078651193955
BAND HETEROTOPIA; BH	0.001759633	0.1159078651193955
WAISMAN SYNDROME; WSMN	0.001759633	0.1159078651193955
JOUBERT SYNDROME 30; JBTS30	0.001759633	0.1159078651193955
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.1159078651193955
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001759633	0.1159078651193955
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001759633	0.1159078651193955
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001759633	0.1159078651193955
SCHAAF-YANG SYNDROME; SHFYNG	0.001759633	0.1159078651193955
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001759633	0.1159078651193955
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001759633	0.1159078651193955
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.1159078651193955
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001759633	0.1159078651193955
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001759633	0.1159078651193955
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001759633	0.1159078651193955
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001759633	0.1159078651193955
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.1159078651193955
XQ25 DUPLICATION SYNDROME	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001759633	0.1159078651193955
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001759633	0.1159078651193955
PALLISTER-HALL SYNDROME	0.001759633	0.1159078651193955
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.1159078651193955
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001759633	0.1159078651193955
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001759633	0.1159078651193955
SALLA DISEASE	0.001759633	0.1159078651193955
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001759633	0.1159078651193955
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001759633	0.1159078651193955
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.1159078651193955
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.001759633	0.1159078651193955
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001759633	0.1159078651193955
CODAS SYNDROME	0.001759633	0.1159078651193955
HYPEREKPLEXIA 4; HKPX4	0.001759633	0.1159078651193955
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001759633	0.1159078651193955
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.1159078651193955
LISSENCEPHALY 1; LIS1	0.001759633	0.1159078651193955
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.1159078651193955
CHROMOSOME 2q37 DELETION SYNDROME	0.001759633	0.1159078651193955
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.001759633	0.1159078651193955
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001759633	0.1159078651193955
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 9	0.001759633	0.1159078651193955
HARTNUP DISORDER	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001759633	0.1159078651193955
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001759633	0.1159078651193955
ELEJALDE DISEASE	0.001759633	0.1159078651193955
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001759633	0.1159078651193955
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001759633	0.1159078651193955
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001759633	0.1159078651193955
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001759633	0.1159078651193955
IMMUNODEFICIENCY 49; IMD49	0.001759633	0.1159078651193955
PHACE ASSOCIATION	0.001759633	0.1159078651193955
611961 STEVENSON-CAREY SYNDROME	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.1159078651193955
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001759633	0.1159078651193955
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.001759633	0.1159078651193955
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.1159078651193955
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001759633	0.1159078651193955
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001759633	0.1159078651193955
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001759633	0.1159078651193955
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.1159078651193955
Cerebral creatine deficiency syndrome 2	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001759633	0.1159078651193955
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001759633	0.1159078651193955
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.1159078651193955
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001759633	0.1159078651193955
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001759633	0.1159078651193955
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001759633	0.1159078651193955
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001759633	0.1159078651193955
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001759633	0.1159078651193955
KETOADIPICACIDURIA	0.001759633	0.1159078651193955
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001759633	0.1159078651193955
LANDAU-KLEFFNER SYNDROME	0.001759633	0.1159078651193955
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.1159078651193955
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001759633	0.1159078651193955
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001759633	0.1159078651193955
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001759633	0.1159078651193955
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001759633	0.1159078651193955
DIGEORGE SYNDROME; DGS	0.001759633	0.1159078651193955
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.1159078651193955
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.1159078651193955
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001759633	0.1159078651193955
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001759633	0.1159078651193955
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001759633	0.1159078651193955
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.1159078651193955
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.1159078651193955
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.1159078651193955
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001759633	0.1159078651193955
PYRUVATE CARBOXYLASE DEFICIENCY	0.001759633	0.1159078651193955
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001759633	0.1159078651193955
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.001759633	0.1159078651193955
MIRAGE SYNDROME; MIRAGE	0.001759633	0.1159078651193955
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.1159078651193955
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.1159078651193955
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.1159078651193955
PEHO SYNDROME; PEHO	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.1159078651193955
CATEL-MANZKE SYNDROME; CATMANS	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001759633	0.1159078651193955
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.001759633	0.1159078651193955
SULFOCYSTEINURIA	0.001759633	0.1159078651193955
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001759633	0.1159078651193955
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001759633	0.1159078651193955
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.1159078651193955
TEMTAMY SYNDROME; TEMTYS	0.001759633	0.1159078651193955
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.001759633	0.1159078651193955
GABA-TRANSAMINASE DEFICIENCY	0.001759633	0.1159078651193955
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001759633	0.1159078651193955
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001759633	0.1159078651193955
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001759633	0.1159078651193955
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001759633	0.1159078651193955
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.001759633	0.1159078651193955
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001759633	0.1159078651193955
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001759633	0.1159078651193955
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.1159078651193955
SHASHI-PENA SYNDROME; SHAPNS	0.001759633	0.1159078651193955
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001759633	0.1159078651193955
LUSCAN-LUMISH SYNDROME; LLS	0.001759633	0.1159078651193955
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001759633	0.1159078651193955
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.1159078651193955
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001759633	0.1159078651193955
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.001759633	0.1159078651193955
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.1159078651193955
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.1159078651193955
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.1159078651193955
MEND SYNDROME; MEND	0.001759633	0.1159078651193955
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.1159078651193955
PETTIGREW SYNDROME	0.001759633	0.1159078651193955
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001759633	0.1159078651193955
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001759633	0.1159078651193955
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001759633	0.1159078651193955
CHROMOSOME 5Q12 DELETION SYNDROME	0.001759633	0.1159078651193955
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001759633	0.1159078651193955
COACH SYNDROME	0.001759633	0.1159078651193955
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.1159078651193955
COFFIN-SIRIS SYNDROME 2; CSS2	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001759633	0.1159078651193955
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00127551	0.08401845216499132
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00127551	0.08401845216499132
ADDUCTED THUMBS SYNDROME	0.00127551	0.08401845216499132
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00127551	0.08401845216499132
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00127551	0.08401845216499132
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00127551	0.08401845216499132
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00127551	0.08401845216499132
VELOCARDIOFACIAL SYNDROME	0.00127551	0.08401845216499132
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.00127551	0.08401845216499132
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00127551	0.08401845216499132
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00127551	0.08401845216499132
NIJMEGEN BREAKAGE SYNDROME	0.00127551	0.08401845216499132
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00127551	0.08401845216499132
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00127551	0.08401845216499132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00127551	0.08401845216499132
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00127551	0.08401845216499132
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.08401845216499132
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.00127551	0.08401845216499132
#615328 SHAHEEN SYNDROME; SHNS	0.00127551	0.08401845216499132
SECKEL SYNDROME 10; SCKL10	0.00127551	0.08401845216499132
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00127551	0.08401845216499132
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.00127551	0.08401845216499132
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00127551	0.08401845216499132
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00127551	0.08401845216499132
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00127551	0.08401845216499132
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00127551	0.08401845216499132
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.00127551	0.08401845216499132
SAY SYNDROME	0.00127551	0.08401845216499132
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00127551	0.08401845216499132
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00127551	0.08401845216499132
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00127551	0.08401845216499132
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00127551	0.08401845216499132
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00127551	0.08401845216499132
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00127551	0.08401845216499132
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00127551	0.08401845216499132
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00127551	0.08401845216499132
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00127551	0.08401845216499132
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00127551	0.08401845216499132
COFFIN-SIRIS SYNDROME 10; CSS10	0.00127551	0.08401845216499132
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00127551	0.08401845216499132
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00127551	0.08401845216499132
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00127551	0.08401845216499132
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00127551	0.08401845216499132
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00127551	0.08401845216499132
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00127551	0.08401845216499132
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00127551	0.08401845216499132
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00127551	0.08401845216499132
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00127551	0.08401845216499132
NEU-LAXOVA SYNDROME 2; NLS2	0.00127551	0.08401845216499132
FRONTONASAL DYSPLASIA 2; FND2	0.00127551	0.08401845216499132
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00127551	0.08401845216499132
FEINGOLD SYNDROME 2; FGLDS2	0.00127551	0.08401845216499132
Cri du Chat Syndrome (5p deletion)	0.00127551	0.08401845216499132
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00127551	0.08401845216499132
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00127551	0.08401845216499132
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00127551	0.08401845216499132
ACHALASIA-MICROCEPHALY SYNDROME	0.00127551	0.08401845216499132
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00127551	0.08401845216499132
ENCEPHALOMALACIA, MULTILOCULAR	0.00127551	0.08401845216499132
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00127551	0.08401845216499132
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00127551	0.08401845216499132
MARTSOLF SYNDROME	0.00127551	0.08401845216499132
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.08401845216499132
MECKEL SYNDROME, TYPE 1; MKS1	0.00127551	0.08401845216499132
OCULOPALATOCEREBRAL SYNDROME	0.00127551	0.08401845216499132
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00127551	0.08401845216499132
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00127551	0.08401845216499132
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00127551	0.08401845216499132
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00127551	0.08401845216499132
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00127551	0.08401845216499132
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00127551	0.08401845216499132
LARYNGEAL ABDUCTOR PARALYSIS	0.00127551	0.08401845216499132
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00127551	0.08401845216499132
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00127551	0.08401845216499132
BLOOM SYNDROME	0.00127551	0.08401845216499132
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00127551	0.08401845216499132
RHIZOMELIC SYNDROME	0.00127551	0.08401845216499132
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00127551	0.08401845216499132
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00127551	0.08401845216499132
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00127551	0.08401845216499132
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00127551	0.08401845216499132
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00127551	0.08401845216499132
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00127551	0.08401845216499132
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00127551	0.08401845216499132
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00127551	0.08401845216499132
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00127551	0.08401845216499132
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.00127551	0.08401845216499132
FACIOCARDIOMELIC SYNDROME	0.00127551	0.08401845216499132
XFE PROGEROID SYNDROME; XFEPS	0.00127551	0.08401845216499132
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00127551	0.08401845216499132
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00127551	0.08401845216499132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00127551	0.08401845216499132
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00127551	0.08401845216499132
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00127551	0.08401845216499132
DE SANCTIS-CACCHIONE SYNDROME	0.00127551	0.08401845216499132
IMMUNODEFICIENCY 55; IMD55	0.00127551	0.08401845216499132
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00127551	0.08401845216499132
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00127551	0.08401845216499132
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00127551	0.08401845216499132
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00127551	0.08401845216499132
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00127551	0.08401845216499132
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00127551	0.08401845216499132
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00127551	0.08401845216499132
PSEUDOTRISOMY 13 SYNDROME	0.00127551	0.08401845216499132
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00127551	0.08401845216499132
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00127551	0.08401845216499132
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00127551	0.08401845216499132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00127551	0.08401845216499132
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00127551	0.08401845216499132
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00127551	0.08401845216499132
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00127551	0.08401845216499132
ROBERTS SYNDROME; RBS	0.00127551	0.08401845216499132
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00127551	0.08401845216499132
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00127551	0.08401845216499132
BOWEN-CONRADI SYNDROME	0.00127551	0.08401845216499132
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00127551	0.08401845216499132
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00127551	0.08401845216499132
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00127551	0.08401845216499132
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.00127551	0.08401845216499132
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00127551	0.08401845216499132
MECKEL SYNDROME, TYPE 4; MKS4	0.00127551	0.08401845216499132
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00127551	0.08401845216499132
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00127551	0.08401845216499132
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00127551	0.08401845216499132
HYPERREFLEXIA	0.00127551	0.08401845216499132
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.00127551	0.08401845216499132
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00127551	0.08401845216499132
SECKEL SYNDROME 4	0.00127551	0.08401845216499132
MICROCEPHALY-CARDIOMYOPATHY	0.00127551	0.08401845216499132
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00127551	0.08401845216499132
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00127551	0.08401845216499132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00127551	0.08401845216499132
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00127551	0.08401845216499132
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00127551	0.08401845216499132
2p15-16.1 microdeletion syndrome	0.00127551	0.08401845216499132
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00127551	0.08401845216499132
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00127551	0.08401845216499132
601453 TRICHODENTAL DYSPLASIA	0.00127551	0.08401845216499132
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00127551	0.08401845216499132
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00127551	0.08401845216499132
CHARGE SYNDROME	0.00127551	0.08401845216499132
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.00127551	0.08401845216499132
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00127551	0.08401845216499132
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00127551	0.08401845216499132
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00127551	0.08401845216499132
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00127551	0.08401845216499132
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00127551	0.08401845216499132
MECKEL SYNDROME 12; MKS12	0.00127551	0.08401845216499132
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00127551	0.08401845216499132
MEIER-GORLIN SYNDROME 8; MGORS8	0.00127551	0.08401845216499132
CARDIAC LIPIDOSIS, FAMILIAL	0.00127551	0.08401845216499132
RUVALCABA SYNDROME	0.00127551	0.08401845216499132
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00127551	0.08401845216499132
FEINGOLD SYNDROME 1; FGLDS1	0.00127551	0.08401845216499132
15q24 recurrent microdeletion syndrome	0.00127551	0.08401845216499132
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00127551	0.08401845216499132
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00127551	0.08401845216499132
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00127551	0.08401845216499132
MENTAL RETARDATION, X-LINKED 63	0.00127551	0.08401845216499132
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.00127551	0.08401845216499132
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00127551	0.08401845216499132
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00127551	0.08401845216499132
GERODERMA OSTEODYSPLASTICUM; GO	0.00127551	0.08401845216499132
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00127551	0.08401845216499132
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00127551	0.08401845216499132
STROMME SYNDROME; STROMS	0.00127551	0.08401845216499132
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00127551	0.08401845216499132
Miller-Dieker syndrome (MDS)	0.00127551	0.08401845216499132
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00127551	0.08401845216499132
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00127551	0.08401845216499132
BARDET-BIEDL SYNDROME 20	0.00127551	0.08401845216499132
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00127551	0.08401845216499132
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00127551	0.08401845216499132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00127551	0.08401845216499132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00127551	0.08401845216499132
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00127551	0.08401845216499132
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00127551	0.08401845216499132
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.060320955216770514
2q33.1 deletion syndrome	0.000915751	0.060320955216770514
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.060320955216770514
HYPERLYSINEMIA, TYPE I	0.000915751	0.060320955216770514
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.060320955216770514
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.060320955216770514
CRANIOSYNOSTOSIS 2	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.060320955216770514
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.060320955216770514
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.060320955216770514
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.060320955216770514
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000915751	0.060320955216770514
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.060320955216770514
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000915751	0.060320955216770514
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.060320955216770514
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.060320955216770514
FLYNN-AIRD SYNDROME	0.000915751	0.060320955216770514
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.060320955216770514
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.060320955216770514
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.060320955216770514
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.060320955216770514
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000915751	0.060320955216770514
15q13.3 microdeletion syndrome	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.060320955216770514
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.060320955216770514
COWDEN SYNDROME 6; CWS6	0.000915751	0.060320955216770514
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.060320955216770514
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.060320955216770514
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.060320955216770514
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000915751	0.060320955216770514
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.060320955216770514
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.060320955216770514
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000915751	0.060320955216770514
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.060320955216770514
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.060320955216770514
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000915751	0.060320955216770514
KUFOR-RAKEB SYNDROME	0.000915751	0.060320955216770514
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.060320955216770514
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.060320955216770514
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.060320955216770514
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000915751	0.060320955216770514
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.060320955216770514
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.060320955216770514
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.060320955216770514
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.060320955216770514
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.060320955216770514
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.060320955216770514
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.060320955216770514
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.000915751	0.060320955216770514
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.060320955216770514
1p36 microdeletion syndrome	0.000915751	0.060320955216770514
NEUROFIBROMATOSIS, TYPE I	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.060320955216770514
HHHH SYNDROME	0.000915751	0.060320955216770514
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.060320955216770514
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.060320955216770514
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000915751	0.060320955216770514
GURRIERI SYNDROME	0.000915751	0.060320955216770514
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000915751	0.060320955216770514
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000915751	0.060320955216770514
POTOCKI-SHAFFER SYNDROME	0.000915751	0.060320955216770514
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.060320955216770514
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000915751	0.060320955216770514
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.060320955216770514
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.060320955216770514
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.060320955216770514
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000915751	0.060320955216770514
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.060320955216770514
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.060320955216770514
FRYNS SYNDROME; FRNS	0.000915751	0.060320955216770514
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.060320955216770514
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.060320955216770514
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.060320955216770514
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.060320955216770514
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.060320955216770514
METACHROMATIC LEUKODYSTROPHY	0.000915751	0.060320955216770514
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000915751	0.060320955216770514
DARIER-WHITE DISEASE; DAR	0.000915751	0.060320955216770514
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.060320955216770514
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000915751	0.060320955216770514
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.060320955216770514
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.060320955216770514
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.060320955216770514
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.060320955216770514
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.060320955216770514
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.060320955216770514
Adrenoleukodystrophy	0.000915751	0.060320955216770514
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.060320955216770514
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.060320955216770514
ALZHEIMER DISEASE 3; AD	0.000915751	0.060320955216770514
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.060320955216770514
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.060320955216770514
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.060320955216770514
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.060320955216770514
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.060320955216770514
ATKIN-FLAITZ SYNDROME	0.000915751	0.060320955216770514
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000915751	0.060320955216770514
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.060320955216770514
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.060320955216770514
ZUNICH NEUROECTODERMAL SYNDROME	0.000915751	0.060320955216770514
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.060320955216770514
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.060320955216770514
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.060320955216770514
FOUNTAIN SYNDROME	0.000915751	0.060320955216770514
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.000915751	0.060320955216770514
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.060320955216770514
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.060320955216770514
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.060320955216770514
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000915751	0.060320955216770514
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.060320955216770514
TENORIO SYNDROME; TNORS	0.000915751	0.060320955216770514
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.060320955216770514
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.060320955216770514
Fabry disease	0.000915751	0.060320955216770514
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000915751	0.060320955216770514
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.060320955216770514
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 47	0.000915751	0.060320955216770514
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.060320955216770514
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.060320955216770514
THREONINEMIA	0.000915751	0.060320955216770514
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000915751	0.060320955216770514
NEURAMINIDASE DEFICIENCY	0.000915751	0.060320955216770514
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.060320955216770514
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.060320955216770514
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.060320955216770514
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.060320955216770514
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.000915751	0.060320955216770514
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.060320955216770514
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.060320955216770514
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.060320955216770514
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.060320955216770514
RAMON SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000915751	0.060320955216770514
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.060320955216770514
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.060320955216770514
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.060320955216770514
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.060320955216770514
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.060320955216770514
STURGE-WEBER SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.060320955216770514
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.060320955216770514
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.060320955216770514
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.060320955216770514
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.060320955216770514
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.060320955216770514
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000915751	0.060320955216770514
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.060320955216770514
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.060320955216770514
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.060320955216770514
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.060320955216770514
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.060320955216770514
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.060320955216770514
ALEXANDER DISEASE	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.060320955216770514
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.060320955216770514
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.000915751	0.060320955216770514
HUNTINGTON DISEASE; HD	0.000915751	0.060320955216770514
TAY-SACHS DISEASE; TSD	0.000915751	0.060320955216770514
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.060320955216770514
CROME SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.060320955216770514
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.000915751	0.060320955216770514
DYSOSTEOSCLEROSIS	0.000915751	0.060320955216770514
THYROCEREBRORETINAL SYNDROME	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.060320955216770514
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.060320955216770514
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.060320955216770514
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.060320955216770514
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.060320955216770514
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.060320955216770514
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.060320955216770514
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.060320955216770514
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.060320955216770514
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.060320955216770514
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.060320955216770514
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.060320955216770514
KEUTEL SYNDROME; KTLS	0.000915751	0.060320955216770514
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.060320955216770514
CLARK-BARAITSER SYNDROME	0.000915751	0.060320955216770514
PARIETAL FORAMINA	0.000915751	0.060320955216770514
DIAMINOPENTANURIA	0.000915751	0.060320955216770514
EPILEPSY, READING	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.060320955216770514
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.060320955216770514
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.060320955216770514
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.060320955216770514
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.060320955216770514
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.060320955216770514
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.060320955216770514
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.060320955216770514
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.060320955216770514
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.060320955216770514
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.060320955216770514
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.060320955216770514
SNEDDON SYNDROME	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.060320955216770514
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.060320955216770514
HYPERPROLINEMIA, TYPE II	0.000915751	0.060320955216770514
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.060320955216770514
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.060320955216770514
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000915751	0.060320955216770514
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.060320955216770514
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.060320955216770514
PAPILLORENAL SYNDROME	0.000915751	0.060320955216770514
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.000915751	0.060320955216770514
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.060320955216770514
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000915751	0.060320955216770514
MAPLE SYRUP URINE DISEASE; MSUD	0.000915751	0.060320955216770514
EPISODIC ATAXIA, TYPE 6	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.060320955216770514
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000915751	0.060320955216770514
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.060320955216770514
COWDEN SYNDROME 5; CWS5	0.000915751	0.060320955216770514
RETT SYNDROME; RTT	0.000915751	0.060320955216770514
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.060320955216770514
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000915751	0.060320955216770514
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.060320955216770514
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.060320955216770514
KIFAFA SEIZURE DISORDER	0.000915751	0.060320955216770514
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.060320955216770514
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000843882	0.05558690990262499
JOUBERT SYNDROME 25	0.000843882	0.05558690990262499
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.05558690990262499
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.000843882	0.05558690990262499
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.05558690990262499
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.05558690990262499
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.05558690990262499
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.05558690990262499
CDAGS SYNDROME	0.000843882	0.05558690990262499
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.05558690990262499
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.05558690990262499
NOONAN SYNDROME 11; NS11	0.000843882	0.05558690990262499
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000843882	0.05558690990262499
JOUBERT SYNDROME 1	0.000843882	0.05558690990262499
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.05558690990262499
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.05558690990262499
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.05558690990262499
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.000843882	0.05558690990262499
MECKEL SYNDROME 13; MKS13	0.000843882	0.05558690990262499
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.05558690990262499
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.05558690990262499
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.05558690990262499
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.05558690990262499
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.05558690990262499
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000843882	0.05558690990262499
JOUBERT SYNDROME 6	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.05558690990262499
JOUBERT SYNDROME 7	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.05558690990262499
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.05558690990262499
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.05558690990262499
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.05558690990262499
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.05558690990262499
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.05558690990262499
Jawad syndrome	0.000843882	0.05558690990262499
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.05558690990262499
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.05558690990262499
LARSEN-LIKE SYNDROME	0.000843882	0.05558690990262499
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.05558690990262499
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.05558690990262499
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.05558690990262499
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000843882	0.05558690990262499
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.05558690990262499
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.05558690990262499
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.05558690990262499
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.05558690990262499
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.05558690990262499
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.05558690990262499
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.05558690990262499
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.05558690990262499
JOUBERT SYNDROME 35; JBTS35	0.000843882	0.05558690990262499
PEROXISOME BIOGENESIS DISORDER 5B	0.000843882	0.05558690990262499
NOONAN SYNDROME 2; NS2	0.000843882	0.05558690990262499
ARIMA SYNDROME	0.000843882	0.05558690990262499
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.05558690990262499
JOUBERT SYNDROME 24	0.000843882	0.05558690990262499
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.05558690990262499
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.05558690990262499
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.05558690990262499
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.05558690990262499
JOUBERT SYNDROME 27	0.000843882	0.05558690990262499
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.05558690990262499
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.05558690990262499
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.05558690990262499
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000843882	0.05558690990262499
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.05558690990262499
CULLER-JONES SYNDROME; CJS	0.000843882	0.05558690990262499
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.05558690990262499
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.05558690990262499
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.05558690990262499
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.05558690990262499
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.05558690990262499
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.05558690990262499
PEROXISOME BIOGENESIS DISORDER 6B	0.000843882	0.05558690990262499
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.05558690990262499
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.05558690990262499
LYMPHEDEMA, HEREDITARY, III	0.000843882	0.05558690990262499
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.05558690990262499
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.05558690990262499
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.05558690990262499
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.05558690990262499
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.05558690990262499
DIAPHANOSPONDYLODYSOSTOSIS	0.000843882	0.05558690990262499
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.05558690990262499
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.05558690990262499
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.05558690990262499
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.05558690990262499
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.05558690990262499
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.05558690990262499
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.05558690990262499
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.05558690990262499
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000843882	0.05558690990262499
HYDROXYKYNURENINURIA	0.000843882	0.05558690990262499
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000843882	0.05558690990262499
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.05558690990262499
Bardet-Biedl syndrome 2	0.000843882	0.05558690990262499
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.05558690990262499
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.05558690990262499
CURRARINO SYNDROME	0.000843882	0.05558690990262499
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000843882	0.05558690990262499
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.05558690990262499
AUSTRALIA ANTIGEN	0.000843882	0.05558690990262499
FRIAS SYNDROME	0.000843882	0.05558690990262499
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.05558690990262499
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.05558690990262499
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.05558690990262499
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.05558690990262499
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000843882	0.05558690990262499
STEEL SYNDROME; STLS	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.05558690990262499
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.05558690990262499
JOUBERT SYNDROME 26	0.000843882	0.05558690990262499
NOONAN SYNDROME 9; NS9	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000843882	0.05558690990262499
JOUBERT SYNDROME 10	0.000843882	0.05558690990262499
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.05558690990262499
JOUBERT SYNDROME 15	0.000843882	0.05558690990262499
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.05558690990262499
Retinitis pigmentosa with or without skeletal anomalies	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.05558690990262499
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.05558690990262499
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.05558690990262499
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.05558690990262499
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.05558690990262499
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.05558690990262499
#614976 CARPENTER SYNDROME 2; CRPT2	0.000843882	0.05558690990262499
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.05558690990262499
NOONAN SYNDROME 6; NS6	0.000843882	0.05558690990262499
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.05558690990262499
SILVER-RUSSELL SYNDROME; SRS	0.000843882	0.05558690990262499
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.05558690990262499
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.05558690990262499
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.05558690990262499
SEPTOOPTIC DYSPLASIA	0.000843882	0.05558690990262499
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.05558690990262499
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.05558690990262499
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.05558690990262499
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.05558690990262499
JOUBERT SYNDROME 28	0.000843882	0.05558690990262499
NOONAN SYNDROME 3; NS3	0.000843882	0.05558690990262499
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.05558690990262499
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.05558690990262499
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000843882	0.05558690990262499
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.05558690990262499
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.05558690990262499
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.05558690990262499
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.05558690990262499
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.05558690990262499
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.05558690990262499
NOONAN SYNDROME 5; NS5	0.000843882	0.05558690990262499
COHEN-GIBSON SYNDROME; COGIS	0.000843882	0.05558690990262499
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.05558690990262499
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.05558690990262499
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.05558690990262499
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.05558690990262499
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.05558690990262499
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.05558690990262499
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000843882	0.05558690990262499
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.05558690990262499
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.05558690990262499
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.05558690990262499
PELLAGRA-LIKE SYNDROME	0.000843882	0.05558690990262499
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.05558690990262499
JOUBERT SYNDROME 8	0.000843882	0.05558690990262499
WAARDENBURG-SHAH SYNDROME	0.000843882	0.05558690990262499
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.05558690990262499
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.05558690990262499
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.05558690990262499
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.05558690990262499
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.05558690990262499
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.05558690990262499
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000843882	0.05558690990262499
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.05558690990262499
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.05558690990262499
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.05558690990262499
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.05558690990262499
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.05558690990262499
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.05558690990262499
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.05558690990262499
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.05558690990262499
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.05558690990262499
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000843882	0.05558690990262499
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.05558690990262499
REVESZ SYNDROME	0.000843882	0.05558690990262499
HURLER SYNDROME	0.000843882	0.05558690990262499
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.05558690990262499
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.05558690990262499
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.05558690990262499
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.05558690990262499
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.05558690990262499
#300555 DENT DISEASE 2	0.000843882	0.05558690990262499
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.05558690990262499
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.05558690990262499
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.05558690990262499
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.05558690990262499
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.05558690990262499
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.05558690990262499
CURRY-JONES SYNDROME	0.000843882	0.05558690990262499
CHOPS SYNDROME; CHOPS	0.000843882	0.05558690990262499
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.05558690990262499
